Skip to main content

Icon Legend
Presentation Icons
Event Add-on
Event Add-on
In Person Only
In Person Only
Off-site Event
Off-site Event
Location: Marriott Marquis
Location: Marriott Marquis

Posters

Posters

  • Tuesday, October 1, 2024
  • 12:45 PM - 2:00 PM ET
    2946 - Spatially Fractionated Radiotherapy (SFRT) for Large Tumors: A Single Institutional Experience of Dosimetry and Clinical Outcomes
    Location: Hall C
    Presenter: Katherine Amarell, MD, BS – Cleveland Clinic Foundation
  • 12:45 PM - 2:00 PM ET
    2947 - Clinical Outcomes and Risk Stratification in Unresectable Biliary Tract Cancers Undergoing Radiation Therapy
    Location: Hall C
    Presenter: Uri Amit, MD, PhD, MPH – Tel Aviv Sourasky Medical Center- Ichilov Hospital
  • 12:45 PM - 2:00 PM ET
    2948 - Outcomes Following Combined Modality Treatment to the Primary Site in Patients with Metastatic Soft Tissue Sarcoma
    Location: Hall C
    Presenter: Andrew Arifin, MD – London Health Sciences Centre
  • 12:45 PM - 2:00 PM ET
    2949 - Rates of Sexual Dysfunction and Prevalence of Estrogen Supplementation after Pelvic Radiation for Women with Early-Onset Rectal Cancer
    Location: Hall C
    Presenter: Angelica Arzola, MSPA – MD Anderson Cancer Center
  • 12:45 PM - 2:00 PM ET
    2950 - Dosimetric Factors Linked to Postoperative Pulmonary Complications and Intensive Care Unit Stay in Locally Advanced Esophageal Cancer Patients Undergoing Preoperative Chemoradiotherapy
    Location: Hall C
  • 12:45 PM - 2:00 PM ET
    2951 - Partial Stereotactic Ablative Radiotherapy Boost before Conventional Radiotherapy (P-SABR) for Large (= 5 cm) Unresectable Soft Tissue Sarcoma
    Location: Hall C
    Presenter: Yun Bai, MD – Peking University First Hospital
  • 12:45 PM - 2:00 PM ET
    2952 - Proton Re-Irradiation for Esophageal Cancer: A Single-Institution Retrospective Series
    Location: Hall C
    Presenter: Mina Bakhtiar, MD – Mass General Brigham/Massachusetts General Hospital/Harvard Med School
  • 12:45 PM - 2:00 PM ET
    2953 - Single Institution Treatment Outcomes for Patients Treated with SBRT for Borderline Resectable Pancreatic Cancer
    Location: Hall C
    Presenter: Leou Ismael Banla, MD, PhD – Harvard Radiation Oncology Program
  • 12:45 PM - 2:00 PM ET
    2954 - Assessing Dose Response and Patterns of Failure in Patients with Node Negative Anal Squamous Cell Carcinoma
    Location: Hall C
    Presenter: Kara Banson, MD – NYU Langone Health- Radiation Oncology
  • 12:45 PM - 2:00 PM ET
    2955 - Phase IA/IB Study of OAR-Based, Dose-Escalated SBRT with Real Time Adaptive MRI Guidance for Liver Metastases: Preliminary Safety and Efficacy Results
    Location: Hall C
    Presenter: Mustafa Basree, DO, MS – University of Wisconsin Hospitals and Clinics
  • 12:45 PM - 2:00 PM ET
    2956 - Ablative Radiotherapy in Patients with Large Volume Liver Metastases and in Those with Prior Liver Directed Therapies: An Analysis of Safety and Local Control
    Location: Hall C
    Presenter: Jared Bassmann, BA – Memorial Sloan Kettering Cancer Center
  • 12:45 PM - 2:00 PM ET
    2957 - Predictors of Local and Distant Recurrence after Neoadjuvant Chemoradiation for Extended Criteria Borderline Resectable Pancreatic Cancer
    Location: Hall C
    Presenter: Cole Billena, MD – Cleveland Clinic Foundation
  • 12:45 PM - 2:00 PM ET
    2958 - Hypertension and Survival Outcomes after Radiotherapy in Esophageal Cancer
    Location: Hall C
    Presenter: Tyren Busby, BS – The Ohio State University Wexner Medical Center
  • 12:45 PM - 2:00 PM ET
    2959 - Feasibility Analysis of Omitting the Clinical Target Volume in Thoracic Radiotherapy for Locally Advanced Esophagus Cancer: A Propensity Score-Matched Cohort Study
    Location: Hall C
    Presenter: Dong-Jie Chen, MS – ShenZhen Cancer Hospital
  • 12:45 PM - 2:00 PM ET
    2960 - Stereotactic Ablative Radiotherapy Combined with Fruquintinib and Tislelizumab in Metastatic Colorectal Cancer: Updated Findings from a Single-Arm, Prospective Phase II Trial (RIFLE)
    Location: Hall C
    Presenter: Yajie Chen, PhD – Fudan University Shanghai Cancer Center
  • 12:45 PM - 2:00 PM ET
    2961 - Short-Course Radiotherapy Combined with Chemotherapy and PD-1 Inhibitor in Proficient Mismatch Repair or Microsatellite Stable (pMMR/MSS) Low-Lying Early Rectal Cancer: Preliminary Findings from a Pro
    Location: Hall C
    Presenter: Yajie Chen, PhD – Fudan University Shanghai Cancer Center
  • 12:45 PM - 2:00 PM ET
    2962 - A Phase II Clinical Trial of Sintilimab Combined with Lower Dose Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
    Location: Hall C
    Presenter: Yicong Chen
  • 12:45 PM - 2:00 PM ET
    2963 - Novel Roles of HOXD11 and HOXD13 in Mediating Response to Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
    Location: Hall C
    Presenter: Zhenguo Shi, MD – Department of Radiation Oncology, Cancer Center, Zhongshan Hospital, Fudan University
  • 12:45 PM - 2:00 PM ET
    2964 - Combining Avelumab with Platinum/5-Fluorouracil and Radical Hypofractionated Radiotherapy for Newly Diagnosed Metastatic Esophageal Squamous Cell Carcinoma: A Phase II Prospective Trial
    Location: Hall C
    Presenter: Jason Chia-Hsien Cheng, MD, PhD, MS, FASTRO – National Taiwan University Hospital
  • 12:45 PM - 2:00 PM ET
    2965 - Alpha Fetoprotein Kinetics in Unresectable Hepatocellular Carcinoma Treated with Concurrent Radiation and Immunotherapy
    Location: Hall C
    Presenter: Daniel Cherry, MD, MAS – Mount Sinai Hospital
  • 12:45 PM - 2:00 PM ET
    2967 - Volumetric Change of Myxoid Liposarcoma During Preoperative Radiotherapy
    Location: Hall C
    Presenter: Pasqualina D'Urso, MD – Regina Elena National Cancer Institute
  • 12:45 PM - 2:00 PM ET
    2968 - Predicting Radiation Induced Immune Suppression Following Radiation Therapy to Pancreatic Cancer
    Location: Hall C
    Presenter: Gabriel Lucas Andrade de Sousa, MS, BS – University of Virginia
  • 12:45 PM - 2:00 PM ET
    2969 - Long-Term Outcomes of More Than a Decade Treating Patients with Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
    Location: Hall C
    Presenter: Wilhelm den Toom, RT – Erasmus MC Cancer Institute
  • 12:45 PM - 2:00 PM ET
    2970 - A Prospective Study to Assess the Role of Neo-Adjuvant Chemoradiation in Locally Advanced Carcinoma Gallbladder
    Location: Hall C
    Presenter: Treshita Dey, MD – PGIMER Chandigarh
  • 12:45 PM - 2:00 PM ET
    2971 - Neoadjuvant Long-Course Radiotherapy Concurrent with Trafluridine Tepirimidine for Locally Advanced Rectal Cancer — A Single-Arm, Multicenter, Phase ? Trial
    Location: Hall C
    Presenter: Xue Dou, MD – Shandong First Medical University and Shandong Academy of Medical Sciences
  • 12:45 PM - 2:00 PM ET
    2972 - Addition of SBRT and Outcomes in Borderline Resectable Pancreatic Cancer Patients Having Suboptimal Response to Neoadjuvant Chemotherapy
    Location: Hall C
    Presenter: Reena Engineer, MD – Tata Memorial Hospital
  • 12:45 PM - 2:00 PM ET
    2973 - mRECIST Outcomes in EMERALD-1: A Phase 3, Randomized, Placebo-Controlled Study of Transarterial Chemoembolization plus Durvalumab with or without Bevacizumab in Participants with Embolization-Eligible
    Location: Hall C
    Presenter: Manila Hada – AstraZeneca
  • 12:45 PM - 2:00 PM ET
    2975 - Microbiome Diversity as a Predictor of Radiation Response and Toxicity in Rectal Cancer
    Location: Hall C
    Presenter: Nicholas Eustace, MD, PhD – City of Hope National Medical Center
  • 12:45 PM - 2:00 PM ET
    2976 - A Randomized, Phase II Clinical Trial of TIme-Restricted Eating vs. Dietary Counseling to Improve Effect of Radiotherapy (TIDIER)
    Location: Hall C
    Presenter: Nicholas Eustace, MD, PhD – City of Hope National Medical Center
  • 12:45 PM - 2:00 PM ET
    2977 - Safety of NBTXR3 Radioenhancer Delivery in Liver Metastases
    Location: Hall C
    Presenter: Benjin Facer, MD – James Cancer Center at Ohio State University
  • 12:45 PM - 2:00 PM ET
    2978 - A Phase II Clinical Trial of Radiotherapy Combined with Anlotinib in Locoregional Recurrent Esophageal Squamous Cell Carcinoma after Radical Surgery
    Location: Hall C
    Presenter: ChengCheng Fan, MD – The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital
  • 12:45 PM - 2:00 PM ET
    2979 - Matched Cohort Analysis of Ultra-Hypofractionated Preoperative Radiation Therapy vs. Standard Fractionation for Soft Tissue Sarcoma
    Location: Hall C
    Presenter: Cong Fan, BS – Cleveland Clinic Lerner College of Medicine
  • 12:45 PM - 2:00 PM ET
    2980 - Clinical Outcomes of Chemoradiotherapy Using Volumetric Modulated Arc Therapy (VMAT) for Locally Advanced Esophageal Cancer: A Single Institute Experience
    Location: Hall C
    Presenter: Syed Raza, BS, MBBS, FCPS – Cancer Care Hospital and Research Center Lahore Pakistan
  • 12:45 PM - 2:00 PM ET
    2981 - Prognostic Immune Markers in Esophageal Cancer Patients Managed with Trimodal Therapy
    Location: Hall C
    Presenter: Mark Farrugia, MD, PhD – Roswell Park Cancer Institute
  • 12:45 PM - 2:00 PM ET
    2982 - Neoadjuvant Radiation Practice Patterns in Resected Pancreatic Ductal Adenocarcinoma at Academic Cancer Centers Participating in the Canopy Cancer Collective Learning Health Network
    Location: Hall C
    Presenter: Fatemeh Fekrmandi, MD, MS – Roswell Park Comprehensive Cancer Center
  • 12:45 PM - 2:00 PM ET
    2983 - Radiation Doses to Small Bowel, Sigmoid and Anal Canal during Preoperative Radiation for Locally Advanced Rectal Cancer: Do They Impact Long-Term Bowel Function?
    Location: Hall C
    Presenter: Ty Forbes, BS – McGovern Medical School
  • 12:45 PM - 2:00 PM ET
    2984 - Treatment Outcomes and Toxicity of Chemoradiation in HIV Positive Patients with Anal Squamous Cell Carcinoma in the Modern Era
    Location: Hall C
    Presenter: Gabriel Fuligni, BS – NYU Grossman School of Medicine
  • 12:45 PM - 2:00 PM ET
    2985 - Immunomodulatory Effects of SBRT in Primary Liver Cancer Patients: Results from the LAPIS Study
    Location: Hall C
    Presenter: Eleni Gkika, MBA
  • 12:45 PM - 2:00 PM ET
    2986 - Liver Cancer Volume Changes during MR Guided SBRT
    Location: Hall C
    Presenter: Aisling Glynn, MD – Princess Margaret Cancer Center, University Health Network
  • 12:45 PM - 2:00 PM ET
    2987 - Outcomes Based on Surgical Timing after Neoadjuvant Therapy for Locally Advanced Esophageal Cancer
    Location: Hall C
    Presenter: Sarah Goodchild, BS, BA – Moffitt Cancer Center
  • 12:45 PM - 2:00 PM ET
    2988 - Neoadjuvant (Chemo-) Radiotherapy for Locally Advanced Soft Tissue Sarcoma
    Location: Hall C
    Presenter: Daniela Greto, MD – Azienda Ospedaliera Universitaria Careggi
  • 12:45 PM - 2:00 PM ET
    2989 - Direct-to-Unit Adaptive Celiac Plexus Radiation Therapy
    Location: Hall C
    Presenter: Beatriz Guevara, MS – University Hospitals Cleveland Medical Center
  • 12:45 PM - 2:00 PM ET
    2990 - Pattern of Primary Tumor Residual and Lymph Node Spread in Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy with or without Pembrolizumab
    Location: Hall C
    Presenter: Xuan Han, MD – Ruijin Hospital, Shanghai Jiaotong University School of Medicine
  • 12:45 PM - 2:00 PM ET
    2991 - Predicting Benefit of Elective Nodal Irradiation in Pancreatic Adenocarcinoma: A Supervised Machine Learning Approach
    Location: Hall C
    Presenter: Garrett Harada, MD – UCI Health
  • 12:45 PM - 2:00 PM ET
    2992 - Effect of Blood Uric Acid on Tumor Regression Response to Preoperative Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
    Location: Hall C
    Presenter: Lei He, MD – Lanzhou university
  • 12:45 PM - 2:00 PM ET
    2993 - Analyzing the Changes of Inflammation-related Cytokines by Using Olink immunoassay during Treatment of SCRT Combined with ICI in Proficient Mismatch Repair locally advanced Rectal Cancer
    Location: Hall C
    Presenter: Nan Xiao, MD – Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
  • 12:45 PM - 2:00 PM ET
    2994 - Predictive Value of Post-Radiotherapy PET with or without MRI to Identify Residual Disease in Patients with Anal Squamous Cell Carcinoma
    Location: Hall C
    Presenter: Sylvia Choo, BA – University of South Florida College of Medicine
  • 12:45 PM - 2:00 PM ET
    2995 - MRI-Defined Moderate Radiation Dose-Escalation for Locally Advanced Pancreas Cancer: A Phase II Study
    Location: Hall C
    Presenter: Jason Hirshberg, DO, MS – Medical College of Wisconsin
  • 12:45 PM - 2:00 PM ET
    2996 - Does Pre-Operative Hypofractionated Radiotherapy Improve Survival in Soft Tissue Sarcomas?
    Location: Hall C
    Presenter: Jason Hirshberg, DO, MS – Medical College of Wisconsin
  • 12:45 PM - 2:00 PM ET
    2997 - Vaginal Melanoma: A Systematic Review of the Literature
    Location: Hall C
    Presenter: Emily Hollis, MD – UNC School of Medicine
  • 12:45 PM - 2:00 PM ET
    2998 - Modeling Radiosensitivity with Gene Interactions Improves the Prediction of Pathological Response to Neoadjuvant Concurrent Chemoradiation in Esophageal Squamous Cell Carcinoma
    Location: Hall C
    Presenter: Feng-Ming Hsu, MD, PhD – National Taiwan University Hospital
  • 12:45 PM - 2:00 PM ET
    2999 - Does Social Vulnerability Index Correlate to Adverse Outcomes in Soft Tissue Sarcoma?
    Location: Hall C
    Presenter: Reese Jacobson, BA – Froedtert Hospital
  • 12:45 PM - 2:00 PM ET
    3000 - Effects of Local Treatment in Combination with Systemic Therapy for Advanced Esophageal Cancer: A Systematic Review and Meta-Analysis
    Location: Hall C
    Presenter: Jianrui Ji, MD
  • 12:45 PM - 2:00 PM ET
    3001 - Efficacy and Safety of the Contrast Agent Gadoterate in the Context of MR-Guided Stereotactic Body Radiotherapy for Upper Abdominal Tumors: A Preliminary Investigation
    Location: Hall C
    Presenter: Wenheng Jiang – Shandong Cancer Hospital and Institute
  • 12:45 PM - 2:00 PM ET
    3002 - MR-Guided Radiotherapy vs. Cone-Beam CT-Guided Radiotherapy for Hepatocellular Carcinoma: A Propensity-Matched Analysis
    Location: Hall C
    Presenter: Wenheng Jiang – Shandong Cancer Hospital and Institute
  • 12:45 PM - 2:00 PM ET
    3003 - Neoadjuvant Tislelizumab Combined with Chemoradiotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Single-Arm Phase II Study and Exploration of Immunologic Features
    Location: Hall C
    Presenter: Peng Jin, PhD
  • 12:45 PM - 2:00 PM ET
    3004 - Safety and Efficacy of Neoadjuvant Chemoradiotherapy with Concurrent Weekly Versus Tri-Weekly Cisplatin/Nab-Paclitaxel in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma
    Location: Hall C
    Presenter: Xuquan Jing – Shandong Cancer Hospital and Institute
  • 12:45 PM - 2:00 PM ET
    3005 - Patterns of Recurrence in High-Risk Gastric Cancer: Defining the Role of Postoperative Radiation
    Location: Hall C
    Presenter: Juan Jose Juarez Vignon Whaley, MD – Beth Israel Deaconess Medical Center
  • 12:45 PM - 2:00 PM ET
    3006 - Efficacy and Safety of Concurrent Radioimmunotherapy for Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma
    Location: Hall C
    Presenter: Ari Kassardjian, MD – City of Hope Comprehensive Cancer Center
  • 12:45 PM - 2:00 PM ET
    3007 - Observed Survival for Esophageal Cancer Patients Receiving High-Dose (>50Gy) vs. Low-Dose (=45.0 Gy) Radiation in Tri-Modality Therapy and Differences in Dose to Thoracic Organs at Risk (OAR)
    Location: Hall C
    Presenter: Cymon Kersch, MD, PhD, MS – Oregon Health and Science University
  • 12:45 PM - 2:00 PM ET
    3007 - Observed Survival for Esophageal Cancer Patients Receiving High-Dose (>50Gy) vs. Low-Dose (=45.0 Gy) Radiation in Tri-Modality Therapy and Differences in Dose to Thoracic Organs at Risk (OAR)
    Location: Hall C
    Presenter: Jason Burton, MD, PhD – Oregon Health and Science University
  • 12:45 PM - 2:00 PM ET
    3008 - Local Control of Merkel Cell Carcinoma Treated with Standard of Care Radiation Therapy Compared to Palliative Dose Radiation Therapy
    Location: Hall C
    Presenter: Reid Thompson, MD, PhD – Oregon Health & Science University
  • 12:45 PM - 2:00 PM ET
    3008 - Local Control of Merkel Cell Carcinoma Treated with Standard of Care Radiation Therapy Compared to Palliative Dose Radiation Therapy
    Location: Hall C
    Presenter: Cymon Kersch, MD, PhD, MS – Oregon Health and Science University
  • 12:45 PM - 2:00 PM ET
    3009 - MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer (MRI-ENHANCE): A Phase I Dose-Escalation Trial for Locally Advanced Rectal Cancer
    Location: Hall C
    Presenter: Emily Kolyvas, PhD – Medical College of Wisconsin (MCW)
  • 12:45 PM - 2:00 PM ET
    3010 - Concurrent Radiation and Immunotherapy for Unresectable Hepatocellular Carcinoma with Portal Vein Thrombus
    Location: Hall C
    Presenter: Nithya Krishnamurthy – Icahn School of Medicine at Mount Sinai
  • 12:45 PM - 2:00 PM ET
    3011 - Phase II Randomized Study of Short Course Radiotherapy Based Total Neo-Adjuvant Therapy and Brachytherapy Boost with or without Chlorophyllin in Reducing the Incidence of Acute Toxicity in Advanced Re
    Location: Hall C
    Presenter: Rahul Krishnatry, MD – Tata Memorial Hospital
  • 12:45 PM - 2:00 PM ET
    3012 - Development of Organs at Risk Constraints for Proton-Based Intensity Modulated Treatment for Prospective Randomized Trial in Anal Cancer
    Location: Hall C
    Presenter: Rahul Krishnatry, MD – Tata Memorial Hospital
  • 12:45 PM - 2:00 PM ET
    3013 - Meta-Analysis of Prospective Randomized Controlled Trials Evaluating of External Beam Radiation vs. Transarterial Chemoembolization for Hepatocellular Carcinoma (HCC)
    Location: Hall C
    Presenter: Ryan Kuehnle, BS – University of Texas Health Science Center San Antonio
  • 12:45 PM - 2:00 PM ET
    3014 - Outcomes and Predictive Factors in Large Hepatocellular Carcinoma Managed with Image-Guided Hypo-Fractionated Radiotherapy
    Location: Hall C
    Presenter: Ritesh Kumar, MD – Rutgers Cancer Institute of New Jersey
  • 12:45 PM - 2:00 PM ET
    3015 - CBCT-Guided Online Adaptive Radiotherapy for Rectal Cancer: Initial Dosimetric and Clinical Experience
    Location: Hall C
    Presenter: Albert Lee, MD – Columbia University Irving Medical Center
  • 12:45 PM - 2:00 PM ET
    3016 - Rates of Hepatotoxicity Following Liver-Directed Ablative External Beam Radiotherapy and Transarterial Radioembolization for Hepatocellular Carcinoma
    Location: Hall C
    Presenter: Grace Lee, MD – Harvard Radiation Oncology Program
  • 12:45 PM - 2:00 PM ET
    3017 - Transarterial Chemoembolization plus Radiotherapy vs. Transarterial Chemoembolization Alone for Single Hepatocellular Carcinoma within BCLC Stage 0-A
    Location: Hall C
    Presenter: Hye In Lee, MD – Seoul National University Hospital
  • 12:45 PM - 2:00 PM ET
    3018 - Tracking the Invisible: Primary Analysis of Real-Time Image Guidance in Liver SBRT from the XXXX : XXXX Trial
    Location: Hall C
    Presenter: Yoo Young Lee, MB, ChB – Princess Alexandra Hospital
  • 12:45 PM - 2:00 PM ET
    3019 - The Role of Oligoprogression Radiotherapy in Delaying Second-Line Therapy in Patients with Hepatocellular Carcinoma
    Location: Hall C
    Presenter: Boyu Leng
  • 12:45 PM - 2:00 PM ET
    3020 - Multi-Modality Machine Learning Prediction Model of Hematologic Toxicity in Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
    Location: Hall C
    Presenter: Bin Li, PhD – Sun Yat-Sen University Cancer Center
  • 12:45 PM - 2:00 PM ET
    3021 - Preoperative Short-Course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor Administration for Locally Advanced Rectal Cancer: The Initial Results of a Randomized Phase II/III Trial (STELLAR II
    Location: Hall C
    Presenter: Haoyue Li, MD
  • 12:45 PM - 2:00 PM ET
    3022 - Longitudinal Dynamic Trajectories of Inflammatory Biomarkers as Prognostic Factors for Esophageal Squamous Cell Carcinoma Patients Receiving Definitive (Chemo)Radiotherapy
    Location: Hall C
    Presenter: Jie Li
  • 12:45 PM - 2:00 PM ET
    3023 - Prognostic Impact of Increased Radiotoxicity in Locally Advanced Esophagus Squamous Cell Cancer Treated with Definitive Chemoradiotherapy
    Location: Hall C
    Presenter: Li Li, MD, PhD, RT – Shandong Cancer Hospital and Institute
  • 12:45 PM - 2:00 PM ET
    3024 - Proteomic Predictive Model Associated with Response to Radical Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Cancer
    Location: Hall C
    Presenter: Li Li, MD, PhD, RT – Shandong Cancer Hospital and Institute
  • 12:45 PM - 2:00 PM ET
    3025 - The Addition of Pembrolizumab to Neoadjuvant Chemoradiotherapy and the Risk of Developing Postoperative Anastomotic Leakage for ESCC: An Analysis from a Prospective Cohort
    Location: Hall C
    Presenter: Shuyan Li, PhD
  • 12:45 PM - 2:00 PM ET
    3026 - The Relationship between Effective Dose to Immune Cells and Vertebral Marrow Dose and Hematologic Toxicity in Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
    Location: Hall C
    Presenter: Zhenjiang Li, PhD – Shandong Cancer Hospital and Institute
  • 12:45 PM - 2:00 PM ET
    3028 - Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma (RICE): A Prospective, Single-Arm, Phase II Trial
    Location: Hall C
    Presenter: Lin Lin, MD – Shanghai Chest Hospital Shanghai Jiao Tong University
  • 12:45 PM - 2:00 PM ET
    3029 - First-Line Low-Dose Radiotherapy with Immunochemotherapy Followed by Conventionally Fractionated Radiotherapy and Immunotherapy in Metastatic Esophageal Squamous Cell Carcinoma: A Phase Ib Trial
    Location: Hall C
    Presenter: Lin Lin, MD – Shanghai Chest Hospital Shanghai Jiao Tong University
  • 12:45 PM - 2:00 PM ET
    3030 - Preliminary Study on Biology-Guided Radiotherapy Planning for Metastatic Liver Lesions Using a Novel O-Ring PET Linac Platform
    Location: Hall C
    Presenter: An Liu, PhD – City of Hope National Medical Center
  • 12:45 PM - 2:00 PM ET
    3031 - Assessing Tumor Regression Grade Accuracy via MRI in Rectal Cancer Patients Following Neoadjuvant Chemoradiotherapy: Impact on Clinical Complete Remission Rate
    Location: Hall C
    Presenter: Guoqing Liu, MD, MS – University of Electronic Science and Technology
  • 12:45 PM - 2:00 PM ET
    3032 - Tumor Immune Microenvironment Remodeling and Prognosis of Patients with Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemotherapy with and without Immunotherapy
    Location: Hall C
    Presenter: Lihong Liu, MS
  • 12:45 PM - 2:00 PM ET
    3033 - Comparative Analysis of Matching Accuracy and Dose Discrepancies: Bone vs. Fiducial Alignment in Free-Breathing Ablative Pancreatic Cancer Radiotherapy
    Location: Hall C
    Presenter: Yilin Liu, PhD – Memorial Sloan Kettering Cancer Center
  • 12:45 PM - 2:00 PM ET
    3034 - Neoadjuvant Immunotherapy Combined with Chemoradiation in Esophageal Cancer: An Individual Patient Data Meta-Analysis
    Location: Hall C
    Presenter: Yunsong Liu, MD – National Cancer Center/National Clinical Research Center for Cancer Cancer Hospital, CAMS & PUMC
  • 12:45 PM - 2:00 PM ET
    3035 - Sintilimab Combined with Definitive Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Single-Arm, Multicenter, Phase 2 Trial
    Location: Hall C
    Presenter: Jiahua Lv, MD, PhD – Sichuan Cancer Hospital and Institute
  • 12:45 PM - 2:00 PM ET
    3036 - Exploratory Study on a Novel Mixed-Dose Liver Radiotherapy Strategy to Reverse Solid Tumor Resistance to Immunotherapy
    Location: Hall C
    Presenter: Hong Ma, MD, PhD – Tongji Hospital Affiliated to Tongji Medical College of Huazhong University
  • 12:45 PM - 2:00 PM ET
    3037 - Clinical Considerations of Splenic Dose Constraints
    Location: Hall C
    Presenter: Yifu Ma – The Second Affiliated Hospital of Soochow University
  • 12:45 PM - 2:00 PM ET
    3038 - Clinical Outcomes Associated with CA 19-9 Dynamics during Chemoradiation in Unresectable Pancreatic Ductal Adenocarcinoma
    Location: Hall C
    Presenter: Serena Mao, MD, PhD – Johns Hopkins Radiation Oncology Kimmel Cancer Center
  • 12:45 PM - 2:00 PM ET
    3039 - Patient Reported Quality of Life and Functional Outcomes after Pre-Operative Chemoradiation for Hilar Cholangiocarcinoma
    Location: Hall C
    Presenter: Tafadzwa Mapiki, DO, BS – Mayo Clinic Rochester
  • 12:45 PM - 2:00 PM ET
    3040 - Patient-Reported Outcomes in Rectal Cancer: A Prospective Study of Treatments with Chemoradiotherapy Alone or Followed by Surgery
    Location: Hall C
    Presenter: Constanza Martinez, MD, PhD – McGill University Health Centre
  • 12:45 PM - 2:00 PM ET
    3044 - A Phase II Trial of Hepatic Ablation of Metastases to Modulate and Enhance Immunotherapy Response (HAMMER) in Non-Small Cell Lung Cancer
    Location: Hall C
    Presenter: Matthew McMillan, MD – Memorial Sloan Kettering Cancer Center
  • 12:45 PM - 2:00 PM ET
    3045 - Radiotherapy for Adolescents and Young Adults with Ewing Sarcoma and Rhabdomyosarcoma Compared to Children
    Location: Hall C
    Presenter: Karin Meijer, MSc – Amsterdam University Medical Center (AUMC)
  • 12:45 PM - 2:00 PM ET
    3046 - Short Course Radiotherapy with Simultaneous Integrated Boost in the Treatment of Rectal Cancer: Clinical and Pathological Response Rates
    Location: Hall C
    Presenter: Michael Melton, MD – University of Alabama Birmingham Hospital
  • 12:45 PM - 2:00 PM ET
    3047 - A Comparative Study on the Determination of Gross Tumor Volume for Hepatocellular Carcinoma Radiotherapy based on Multi-Phase Contrast-Enhanced Magnetic Resonance Imaging
    Location: Hall C
  • 12:45 PM - 2:00 PM ET
    3048 - Stereotactic Body Radiation Following Prior Radiotherapy for Pancreatic Cancer: A Single Institution Experience
    Location: Hall C
    Presenter: Mohammed Mohammed, MD – UPMC Hillman Cancer Center
  • 12:45 PM - 2:00 PM ET
    3049 - Adaptive MR-Guided Stereotactic Ablative Body Radiotherapy (MRgSABR) for Pancreas Cancer: Dosimetric Evaluation from EMERALD Trial
    Location: Hall C
    Presenter: Elena Moreno-Olmedo, MD – GenesisCare
  • 12:45 PM - 2:00 PM ET
    3050 - Implementation and Early Outcomes of Stereotactic Body Radiotherapy for Treating Hepatocellular Carcinoma at a Latin American Institution
    Location: Hall C
    Presenter: Pablo Munoz Schuffenegger, MD – Pontificia Universidad Catolica de Chile
  • 12:45 PM - 2:00 PM ET
    3051 - Image-Guided Proton Therapy for Unresectable Trunk Soft-Tissue Sarcoma
    Location: Hall C
    Presenter: Koichiro Nakajima, MD, PhD – Nagoya Proton Therapy Center
  • 12:45 PM - 2:00 PM ET
    3052 - Neoadjuvant Short-Course Radiotherapy Followed by Chemotherapy for Rectal Adenocarcinoma: Analysis of Clinical and Pathological Responses of Patients Treated in a Brazilian Tertiary General Hospital
    Location: Hall C
    Presenter: Marta Nassif Pereira-Lima, MD – Hospital Moinhos de Vento
  • 12:45 PM - 2:00 PM ET
    3053 - Comparison of External Beam Radiation Modalities (Photon vs. Proton vs. Carbon Ion) in the Treatment of Hepatocellular Carcinoma: A Network Metanalysis
    Location: Hall C
    Presenter: David Nganga, MD, BS – University of North Carolina Hospitals
  • 12:45 PM - 2:00 PM ET
    3054 - Dosimetric Analysis of Stereotactic vs. Intensity-Modulated Radiation Therapy for Pancreatic Cancer
    Location: Hall C
    Presenter: Patrick Oh, MD – Yale School of Medicine
  • 12:45 PM - 2:00 PM ET
    3055 - Promising Pathologic Response of Spatially Fractionated Radiotherapy Preceding Standard Neoadjuvant Conventionally Fractionated Radiotherapy in Aggressive Soft Tissue Sarcoma
    Location: Hall C
    Presenter: Adeniyi Olabumuyi, MB, BS, MB, BS – University of Maryland Medical Center
  • 12:45 PM - 2:00 PM ET
    3056 - Predicting Pathological Lymph Node Involvement Using Machine Learning in Locally Advanced Rectal Cancer Patients Treated with Neoadjuvant Chemo-Radiotherapy
    Location: Hall C
    Presenter: Gulsah Ozden, MD – Marmara University
  • 12:45 PM - 2:00 PM ET
    3057 - Efficacy of Immune Checkpoint Inhibitors in Advanced Esophageal Squamous Cell Carcinoma Patients with Hepatitis B
    Location: Hall C
    Presenter: Junfan Pan, PhD – Fujian Medical University
  • 12:45 PM - 2:00 PM ET
    3058 - Increased Tumor Size and Progression Free Survival after 177Lu-DOTATATE for Metastatic Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
    Location: Hall C
    Presenter: Jimmy Patel, MD, PhD – Emory University
  • 12:45 PM - 2:00 PM ET
    3059 - Disparities in Diagnosis and Access to Care in Patients with Young-Onset Colorectal Cancers in Northeast Ohio
    Location: Hall C
    Presenter: Rohan Patel, MD – UH Seidman Cancer Center Case Western Reserve University
  • 12:45 PM - 2:00 PM ET
    3060 - Matched Pair Analysis of Locally Advanced Pancreatic Cancer Patients Treated with Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy (MAPLAP)
    Location: Hall C
    Presenter: Reena Engineer, MD – Tata Memorial Hospital
  • 12:45 PM - 2:00 PM ET
    3061 - Ablative MRI-Guided Radiation for GI Neuroendocrine Tumors: Assessment of Local Control and Toxicity
    Location: Hall C
    Presenter: John Peterson, MD – H. Lee Moffitt Cancer Center and Research Institute
  • 12:45 PM - 2:00 PM ET
    3062 - Toward Non-Operative Management of Locally Advanced Rectal Cancer Patients Undergoing Short Course Chemoradiotherapy: Early Response Prediction via Longitudinal Apparent Diffusion Coefficient
    Location: Hall C
    Presenter: Jonathan Pham, PhD – UCLA
  • 12:45 PM - 2:00 PM ET
    3063 - Safe Distance for Ovarian Transposition Prior to Pelvic Radiation Therapy for Lower GI Cancers
    Location: Hall C
  • 12:45 PM - 2:00 PM ET
    3064 - First Exploration of the Characterization and Dosimetric Predictors for Absolute Lymphocyte Count Changes during nCRT with or without Pembrolizumab for Esophageal Squamous Cell Carcinoma: An Analysis
    Location: Hall C
    Presenter: Wei-Xiang Qi, MD, RT – Ruijin Hospital, Shanghai Jiaotong University School of Medicine
  • 12:45 PM - 2:00 PM ET
    3065 - Frailty Index and Early Mortality in Older Adults with Gastrointestinal Malignancies Treated with Radiation
    Location: Hall C
    Presenter: Katelyn Ragland, MD – University of Alabama at Birmingham
  • 12:45 PM - 2:00 PM ET
    3066 - Safety and Efficacy of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma in Patients with Advanced Cirrhosis Awaiting Liver Transplantation: An ROI-funded Prospective Pilot Study
    Location: Hall C
    Presenter: Ramtin Rahmani, BS – Oregon Health and Science University
  • 12:45 PM - 2:00 PM ET
    3067 - Alliance A022101/NRG-GI009: A Pragmatic Randomized Phase III Trial Evaluating Total Ablative Therapy for Patients with Limited Metastatic Colorectal Cancer - Evaluating Radiation, Ablation and Surgery
    Location: Hall C
    Presenter: Paul Romesser, MD – Memorial Sloan Kettering Cancer Center
  • 12:45 PM - 2:00 PM ET
    3068 - Radiosensitization Adding Hydrogen Peroxide to Neoadjuvant Chemoradiotherapy of Rectal Cancer
    Location: Hall C
    Presenter: Anneyuko Saito, MD, PhD – Juntendo University Faculty of Medicine
  • 12:45 PM - 2:00 PM ET
    3069 - Sinonasal Melanoma Outcomes after Neoadjuvant Immunotherapy
    Location: Hall C
    Presenter: Aya Salem, MD – MD Anderson Cancer Center
  • 12:45 PM - 2:00 PM ET
    3070 - Efficacy and Safety of Toripalimab Combined with Radiotherapy and S-1 Followed by Adjuvant Toripalimab Maintenance Therapy for Older Patients with Esophageal Cancer
    Location: Hall C
    Presenter: Wen Bin Shen, MD – The Fourth Hospital of Hebei Medical University
  • 12:45 PM - 2:00 PM ET
    3071 - Outcomes of Salvage Ablative Radiotherapy on Hepatocellular Carcinoma for Isolated Location Recurrence in Regional Lymph Nodes and Adrenal Glands
    Location: Hall C
    Presenter: Kristin Hsieh, MD – Icahn School of Medicine at Mount Sinai
  • 12:45 PM - 2:00 PM ET
    3072 - A Prospective Pilot Study of Cardiac MRI (cMRI) for Evaluation of Early Cardiac Toxicity in Patients Receiving Neoadjuvant Chemoradiotherapy (nCRT) for Esophageal Cancer
    Location: Hall C
    Presenter: Muhammad Shuja, MD – Mayo Clinic Rochester
  • 12:45 PM - 2:00 PM ET
    3073 - Predicting Patient-Specific Benefits in Pancreatic Cancer Adaptive Radiotherapy: A Machine Learning Approach
    Location: Hall C
    Presenter: Adam Riegel, PhD – Columbia University Irving Medical Center
  • 12:45 PM - 2:00 PM ET
    3074 - Survival Outcomes for Gastrointestinal Stromal Tumors between Geriatric and Non-Geriatric Patients from 2000-2019
    Location: Hall C
    Presenter: Abhiram Singh – Northwell Health
  • 12:45 PM - 2:00 PM ET
    3075 - Locally Advanced Rectal Cancer: Can Total Mesorectal Irradiation Decrease Pelvic Toxicity?
    Location: Hall C
    Presenter: Pranit Singh, BS – USF Health Morsani College of Medicine
  • 12:45 PM - 2:00 PM ET
    3076 - EMERALD-Y90: A Phase 2 Study to Evaluate Transarterial Radioembolization Followed by Durvalumab and Bevacizumab for the Treatment of Unresectable Hepatocellular Carcinoma Eligible for Embolization
    Location: Hall C
    Presenter: Benjamin Spieler, MD – Sylvester Comprehensive Cancer Center
  • 12:45 PM - 2:00 PM ET
    3077 - Enhancing Radiotherapy Response via Intratumoral Injection of the TLR9 Agonist CpG to Stimulate CD8 T Cells in an Autochthonous Mouse Model of Sarcoma
    Location: Hall C
    Presenter: Chang Su, BS – Duke University
  • 12:45 PM - 2:00 PM ET
    3078 - Prognosis and Treatment Outcomes of Oligometastatic Melanoma with Intracranial Involvement
    Location: Hall C
    Presenter: Andrew Tam, MD – City of Hope National Medical Center
  • 12:45 PM - 2:00 PM ET
    3079 - MRI as a Biomarker for Pelvic Floor Atrophy in Rectal Cancer Patients Undergoing Chemoradiation Therapy
    Location: Hall C
    Presenter: Rehema Thomas, MD – MD Anderson Cancer Center
  • 12:45 PM - 2:00 PM ET
    3080 - Outcomes and Predictors of Toxicity after Stereotactic Body Radiotherapy for Child-Pugh B or C Hepatocellular Carcinoma in a Fiducial-Less Setting
    Location: Hall C
    Presenter: Rituraj Upadhyay, MD, MBBS, DNB – Ohio State University
  • 12:45 PM - 2:00 PM ET
    3081 - Functionally Guided NTCP Modeling Using DCE-MRI in Hepatocellular Carcinoma
    Location: Hall C
    Presenter: Christian Velten, MSc – Montefiore Medical Center
  • 12:45 PM - 2:00 PM ET
    3082 - Long-Term Outcomes after Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer
    Location: Hall C
    Presenter: Alberto Vera, MD – UPMC Cancer Center
  • 12:45 PM - 2:00 PM ET
    3083 - Tradeoffs in Patient Decision Making about Rectal Cancer Treatment: Early Results from The PATHOS Study
    Location: Hall C
    Presenter: Te Vuong, MD – McGill University
  • 12:45 PM - 2:00 PM ET
    3084 - Optimizing Eligibility for and Access to Non-Operative Management for Rectal Adenocarcinoma
    Location: Hall C
    Presenter: Kathleen Waeldner, BA – Robert Larner, MD College of Medicine at the University of Vermont
  • 12:45 PM - 2:00 PM ET
    3085 - Comprehensive Evaluation of the Effects of Immune Rich Organs on Radiation Induced Immune Suppression during Radiation Therapy to Pancreas
    Location: Hall C
    Presenter: Kristin Walker, MD, MBA – UVA Department of Radiation Oncology
  • 12:45 PM - 2:00 PM ET
    3086 - LASSO Regression to Identify Significant Patient Factors and Develop Survival Model in Patients with Cutaneous Melanoma: Results of 20,981 Cases from SEER Database
    Location: Hall C
    Presenter: Huiwei Wang
  • 12:45 PM - 2:00 PM ET
    3087 - Multi-Omics Sequencing Unveils Tumor Microenvironment Remodeling Induced by Combined Radiotherapy and Immunotherapy in Microsatellite-Stable Locally Advanced Rectal Cancer
    Location: Hall C
    Presenter: Zhen Zhang, MD, PhD – Fudan University Shanghai Cancer Center
  • 12:45 PM - 2:00 PM ET
    3088 - Pathological Response and Survival Outcome after Neoadjuvant Chemoradiotherapy vs. Immunochemotherapy for Patients with Locally Advanced Esophageal Squamous Cell Carcinoma
    Location: Hall C
    Presenter: Jun Wang, PhD
  • 12:45 PM - 2:00 PM ET
    3089 - Efficacy and Safety of Radiotherapy Combined with Chemoimmunotherapy vs. Chemoimmunotherapy Alone as First-Line Treatment for Advanced Esophageal Squamous Cell Carcinoma with Oligorecurrence
    Location: Hall C
    Presenter: Jun Wang, PhD
  • 12:45 PM - 2:00 PM ET
    3090 - Radiotherapy Combined with Chemoimmunotherapy vs. Chemoimmunotherapy Alone As First-Line Treatment for Advanced Esophageal Squamous Cell Carcinoma with Oligometastasis at Initial Diagnosis
    Location: Hall C
    Presenter: Jun Wang, PhD
  • 12:45 PM - 2:00 PM ET
    3091 - Simultaneous Integrated Boost Intensity-Modulated Radiotherapy (SIB-IMRT) Combined with Nimotuzumab for Locally Advanced Esophageal Squamous Cell Carcinoma (ESCC): A Phase ? Clinical Trial
    Location: Hall C
    Presenter: Lan Wang, MD
  • 12:45 PM - 2:00 PM ET
    3092 - Phase II Study of Sintilimab Combined with Chemotherapy and Sequential Radiotherapy in First-Line Treatment of Oligometastatic Esophageal Cancer
    Location: Hall C
    Presenter: Linlin Wang, MD, PhD – Shandong Cancer Hospital and Institute
  • 12:45 PM - 2:00 PM ET
    3093 - Toripalimab plus Chemotherapy and Radiotherapy for Treatment-Naive, Advanced Esophageal Squamous Cell Carcinoma: A Single-Arm Phase II Trial
    Location: Hall C
    Presenter: Qifeng Wang, MD, PhD – Sichuan Cancer Hospital and Institute
  • 12:45 PM - 2:00 PM ET
    3094 - Tislelizumab plus Chemotherapy Sequential Neoadjuvant Therapy for Non-cCR Patients after Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma (ETNT): An Exploratory Stu
    Location: Hall C
    Presenter: Qifeng Wang, MD, PhD – Sichuan Cancer Hospital and Institute
  • 12:45 PM - 2:00 PM ET
    3095 - Evaluation of Breath-Hold Techniques for Pancreatic Cancer Stereotactic Ablative Radiotherapy via Intra-Fractional Kilo-Voltage Imaging and Fiducial Tracking
    Location: Hall C
    Presenter: Siqiu Wang, PhD – University of Texas Southwestern Medical Center
  • 12:45 PM - 2:00 PM ET
    3096 - Evaluating the Long-term Outcomes of Preoperative Radiation and Conservative Surgery in Extremity and Trunk Soft Tissue Sarcoma
    Location: Hall C
    Presenter: Nattinee Wattakiyanon, MD, RT – Princess Margaret Cancer Center, University Health Network
  • 12:45 PM - 2:00 PM ET
    3097 - Preoperative Short-Course Radiotherapy Combined with Chemotherapy and Tislelizumab for Locally Advanced Middle-Low Rectal Cancer: A Randomized Phase I/II Clinical Study
    Location: Hall C
    Presenter: Lichun Wei, PhD, CMD – Xijing Hospital
  • 12:45 PM - 2:00 PM ET
    3098 - Evaluation of Fiducial Motion during Treatment of Upper Abdominal Lymph Nodes with Stereotactic Body Radiation Therapy
    Location: Hall C
    Presenter: Matthew Abrams, MD – Beth Israel Deaconess Medical Center
  • 12:45 PM - 2:00 PM ET
    3100 - Sarcopenia as an Independent Prognostic Factor for Neoadjuvant Chemoradiation Efficacy in Locally Advanced Rectal Cancer: A Retrospective Analysis
    Location: Hall C
    Presenter: Jeng-You Wu, MD, MBA – Taipei Municipal WanFang Hospital
  • 12:45 PM - 2:00 PM ET
    3101 - Prognostic Nomogram for Prediction of Progression Free Survival after Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
    Location: Hall C
    Presenter: Qi-Qiao Wu, MD, PhD Candidate – Fudan Univerisity Zhongshan Hospital(Xiamen)
  • 12:45 PM - 2:00 PM ET
    3103 - Comparison of Radiation Esophagitis Associated with Morning vs. Evening Radiotherapy in Patients with Esophageal Squamous Cell Carcinoma
    Location: Hall C
    Presenter: Geng Xiang
  • 12:45 PM - 2:00 PM ET
    3104 - Comparison of Anlotinib and S-1 Combined with Radiotherapy in the Treatment of Elderly Patients with Inoperable Esophageal Squamous Cell Cancer: An Open-Label, Phase 2, Randomized Controlled Trial
    Location: Hall C
    Presenter: Geng Xiang
  • 12:45 PM - 2:00 PM ET
    3105 - Prognostic Value of Sarcopenia and Inflammatory Indices Synergy in Patients with Esophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy
    Location: Hall C
    Presenter: Ling Xiao, MD, PhD – Sichuan Cancer Hospital and Institute
  • 12:45 PM - 2:00 PM ET
    3106 - A Single Arm Phase II Study of Neoadjuvant Chemoradiotherapy and AK104 in pMMR/MSS Locally Advanced Rectal Cancer with Positive PD-L1 Expression
    Location: Hall C
    Presenter: WeiWei Xiao, MD, PhD – Sun Yat-Sen University Cancer Center
  • 12:45 PM - 2:00 PM ET
    3107 - A Real-World Long-Term Outcome of Intensity-Modulated Radiation Therapy plus Concurrent Chemotherapy in Locally Advanced Anal Squamous Cell Carcinoma
    Location: Hall C
    Presenter: Tongzhen Xu, MD – Chinese Academy of Medical Science
  • 12:45 PM - 2:00 PM ET
    3108 - The Japanese Nationwide Prospective Cohort Data of Proton Beam Therapy for Liver Oligometastasis in Pancreatic Cancer Patients
    Location: Hall C
    Presenter: Hisashi Yamaguchi, MD, PhD – The Ohio State University
  • 12:45 PM - 2:00 PM ET
    3109 - Survival and Follow-Up Strategies of Watch-and-Wait Patients with a Clinical Complete Response after Selective High-Dose Neoadjuvant Radiotherapy in Rectal Cancer
    Location: Hall C
    Presenter: Chen Yang, MD – Sun Yat-Sen University Cancer Center
  • 12:45 PM - 2:00 PM ET
    3110 - Neoadjuvant Chemoradiotherapy plus Sequential Tislelizumab Followed by Surgery for Esophageal Carcinoma (CRISEC study): A Prospective, Single-Arm, Phase II Trial
    Location: Hall C
    Presenter: Jinsong Yang, MD – Cancer Institute and Hospital Chinese Acedemy of Medical Sciences
  • 12:45 PM - 2:00 PM ET
    3111 - Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) for the Treatment of Gastrointestinal Cancers
    Location: Hall C
    Presenter: Orly Yariv, MD – National Cancer Inst
  • 12:45 PM - 2:00 PM ET
    3112 - The Role of Tumor Location and Motion in Local Failures after Radiation Therapy for Hepatocellular Carcinoma
    Location: Hall C
    Presenter: Pete Yeh, MD – University of Washington School of Medicine
  • 12:45 PM - 2:00 PM ET
    3114 - The Outcomes of Moderately-Hypofractionated Intensity Modulated Radiotherapy for Unresectable Locally Advanced Pancreatic Cancer
    Location: Hall C
    Presenter: Michio Yoshimura, MD, PhD – Kyoto University
  • 12:45 PM - 2:00 PM ET
    3115 - Final Results of the First Clinical Trial of a Novel Unidirectional Permanent Device for Intraoperative Brachytherapy
    Location: Hall C
    Presenter: Irini Youssef, MD – Memorial Sloan Kettering Cancer Center
  • 12:45 PM - 2:00 PM ET
    3116 - "Pacific" Modality in Locally Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Analysis of a Real-World Multicenter Study
    Location: Hall C
    Presenter: Nuo Yu, BS
  • 12:45 PM - 2:00 PM ET
    3117 - Chemoradioimmunotherapy Followed by Chemoimmunotherapy is Tolerable and Feasible in Inoperable Biliary Tract Cancer: A Phase Ib Clinical Trial
    Location: Hall C
    Presenter: Jinbo Yue, MD, PhD – Shandong Cancer Hospital and Institute
  • 12:45 PM - 2:00 PM ET
    3118 - President: A Randomised Phase III Trial of Preoperative Chemoradiation Versus Post Operative Chemoradiation for Locally Advanced Potential Resectable Gastric Cancer.
    Location: Hall C
    Presenter: Ming Zeng, MD, PhD – Sichuan Taikang Hospital
  • 12:45 PM - 2:00 PM ET
    3119 - Radiotherapy in Patients with Early-Onset Pancreatic Cancer: Clinical Characteristics and Treatment Outcomes
    Location: Hall C
    Presenter: Letian Zhang, MD – Chinese PLA General Hospital
  • 12:45 PM - 2:00 PM ET
    3120 - Radiotherapy Delays Second-Line Drug Therapy for Oligo Progressive Hepatocellular Carcinoma: A Multicenter, Single-Arm, Phase II Clinical Trial
    Location: Hall C
    Presenter: Xiang Zhang, MD, PhD – Shandong Cancer Hospital and Institute
  • 12:45 PM - 2:00 PM ET
    3121 - Pathological Response and Locoregional Control in Gastric Cancer Patients after Preoperative Chemoradiation Versus Preoperative Chemotherapy: Data from the Neo-Crag Clinical Trial
    Location: Hall C
    Presenter: Yujing Zhang, MD, PhD – Sun Yat-Sen University Cancer Center
  • 12:45 PM - 2:00 PM ET
    3122 - Cellular Senescence Index Predicts Radiotherapy Response and Outcomes in Esophagus Cancer Patients
    Location: Hall C
    Presenter: Zengfu Zhang, MD – Shandong Cancer Hospital and Institute
  • 12:45 PM - 2:00 PM ET
    3123 - Improving Resectability and Prognosis in Initially Unresectable Locally Advanced Colon Cancer through Neoadjuvant Chemoradiotherapy: A Single-Center Retrospective Study
    Location: Hall C
    Presenter: Zi-tong Zhang, MD – Sun Yat-Sen University Cancer Center
  • 12:45 PM - 2:00 PM ET
    3124 - Dosimetric Predictors of Acute Hematological Toxicity during nCRT with or without Pembrolizumab for Esophageal Squamous Cell Carcinoma
    Location: Hall C
    Presenter: Zhao Chaofen, MD
  • 12:45 PM - 2:00 PM ET
    3125 - Efficacy and Safety of the Combination of Tislelizumab with Chemoradiotherapy in Oligorecurrence Esophageal Squamous Cell Carcinoma: A Prospective Phase II Study
    Location: Hall C
    Presenter: ziyu zheng, MB – National Cancer Center/National Clinical Research Center for Cancer Cancer Hospital, CAMS & PUMC
  • 12:45 PM - 2:00 PM ET
    3126 - Efficacy and Safety of PD-1 Inhibitors and Targeted Drugs Combined with Radiotherapy in First-Line Treatment of Oligometastatic Hepatocellular Carcinoma
    Location: Hall C
    Presenter: Kunli Zhu
  • 12:45 PM - 2:00 PM ET
    3127 - Ablative Treatment with CT Guided Adaptive Radiation Therapy for Pancreatic Cancer
    Location: Hall C
    Presenter: Tiffany Zhu – Washington University School of Medicine
  • 12:45 PM - 2:00 PM ET
    3128 - Mortality And Equitability of Radiation Treatment in Locally Advanced Rectal Cancer: A Review from a National Cohort
    Location: Hall C
  • 2:30 PM - 3:45 PM ET
    3129 - Assessment of Pattern of Requirement of General Anesthesia for Pediatric Patients Undergoing Radiotherapy
    Location: Hall C
    Presenter: Aashita Aashita, MD – NCI AIIMS
  • 2:30 PM - 3:45 PM ET
    3130 - Early PSA Kinetics in Patients Treated with Prostate SBRT with Intra-Prostatic Boost
    Location: Hall C
    Presenter: Nima Aghdam, MD, MS – Beth Israel Deaconess Medical Center
  • 2:30 PM - 3:45 PM ET
    3131 - National Value-Based Care Competition - A Six Sigma Training Program
    Location: Hall C
    Presenter: James Alin, BS – Medical College of Georgia
  • 2:30 PM - 3:45 PM ET
    3132 - Ablative Radiotherapy for Unfavorable Prostate Tumors (ABRUPT): Analysis of Toxicity and Quality of Life from a Prospective Study
    Location: Hall C
    Presenter: Stefano Arcangeli, MD – University of Milan Bicocca
  • 2:30 PM - 3:45 PM ET
    3133 - Utilizing of a Dedicated Radiation Oncology Documentation Software Designed with Physician Input and Note Completion Times
    Location: Hall C
    Presenter: Joshua Asper, PA-C – Mays Cancer Center, UT Health San Antonio, MD Anderson Cancer Center
  • 2:30 PM - 3:45 PM ET
    3134 - Managing for Daily Improvement: A System for Real-Time Quality Improvement and Patient Safety
    Location: Hall C
    Presenter: Margaret Barker, MS – MemorialCare Long Beach Medical Center
  • 2:30 PM - 3:45 PM ET
    3135 - Node Positive Prostate Cancer Treated with Brachytherapy Boost
    Location: Hall C
    Presenter: Rahul Barve, MD – Memorial Sloan Kettering Cancer Center
  • 2:30 PM - 3:45 PM ET
    3136 - Patient Reported Quality of Life (QOL) Outcomes for Intermediate-High Risk-Very High Risk Prostate Cancers Treated By SBRT and Androgen Deprivation Therapy (ADT)
    Location: Hall C
    Presenter: Trinanjan Basu, MD – HCG Cancer Center, Mumbai
  • 2:30 PM - 3:45 PM ET
    3137 - Association of Tumor Volume and Radiographic T-Stage for Patients with Localized Prostate Cancer Treated with Radiation or Radical Prostatectomy
    Location: Hall C
    Presenter: Martin King, MD, PhD – Brigham and Womens Hospital
  • 2:30 PM - 3:45 PM ET
    3138 - Daily Adaptive Post-Prostatectomy Radiation Therapy (DAPPER): Initial Treatment Planning and Delivery Outcomes Using CT-Based Online Adaptive Radiation Therapy
    Location: Hall C
    Presenter: Alexandra Bennett, MD – Mayo Clinic College of Medicine and Science Rochester
  • 2:30 PM - 3:45 PM ET
    3139 - Effectiveness of an Iodinated Perirectal Hydrogel Spacer for Prostate Cancer Treated with Stereotactic Body Radiotherapy (SBRT): A Prospective, Multi-Center, Randomized Trial ("SABRE")
    Location: Hall C
    Presenter: Pierre Blanchard, MD, PhD – Gustave Roussy Cancer Center
  • 2:30 PM - 3:45 PM ET
    3140 - Development of a Consensus Checklist for Systematic Radiation Treatment Plan Review
    Location: Hall C
    Presenter: Graham Boyd, MD – Dana-Farber/Brigham and Women's Cancer Center
  • 2:30 PM - 3:45 PM ET
    3141 - MRI-Guided Adaptive SBRT for Kidney and Adrenal Gland Tumors: An Analysis of the Intra-Fractional Tumor Motion and Inter-Fractional Dosimetric Impact
    Location: Hall C
    Presenter: Lingling Cai, MB – Sun Yat-Sen University Cancer Center
  • 2:30 PM - 3:45 PM ET
    3142 - 3D-Printed Seed Placement Template for 125I Seed Plaque Assembly with Custom Eye Plaques
    Location: Hall C
    Presenter: Kaitlyn Calabresi, BS – Louisiana State University Health Sciences Center
  • 2:30 PM - 3:45 PM ET
    3143 - Geographical Comparison of Medicare & Medicaid Services (CMS) Standard Charges for Complex Proton Therapy
    Location: Hall C
    Presenter: Kasey Cargill, PhD – University of Pittsburgh School of Medicine
  • 2:30 PM - 3:45 PM ET
    3144 - Severe Genitourinary Events Following Definitive Radiation Therapy for Patients with Locally Advanced and Metastatic Bladder Cancer: A Single Institution Experience
    Location: Hall C
    Presenter: Patrick Carriere, MD, PhD – MD Anderson Cancer Center
  • 2:30 PM - 3:45 PM ET
    3145 - An LLM-Based Framework for Zero-Shot De-Identifying Flexible Text Data in Protected Health Information Enabling Potential Risk-Informed Patient Safety
    Location: Hall C
    Presenter: Chih-Wei Chang, PhD – Emory University
  • 2:30 PM - 3:45 PM ET
    3146 - Stereotactic Body Radiotherapy for Prostate Cancer with Magnetic Resonance Imaging or Computed Tomography Guidance
    Location: Hall C
    Presenter: Enoch Chang, MD – MD Anderson Cancer Center
  • 2:30 PM - 3:45 PM ET
    3147 - Clinical Efficacy and Adverse Effects of Adjuvant Radiotherapy Following Surgery in High-Risk Renal Cell Carcinoma(RCC) Patients - A Single Center Experience
    Location: Hall C
    Presenter: Jiayan Chen, MD – Peking University First Hospital
  • 2:30 PM - 3:45 PM ET
    3148 - Racial Variation in the Advanced Prostate Cancer Genome
    Location: Hall C
    Presenter: William Chen, MD – UCSF
  • 2:30 PM - 3:45 PM ET
    3149 - Care Coordination for Patients with Cardiac Implantable Electronic Devices Scheduled to Receive Radiation
    Location: Hall C
    Presenter: Walter Chin, MS, BSN – Emory Clinic
  • 2:30 PM - 3:45 PM ET
    3150 - Treatment Terminations during Radiation Therapy: A Decade of Genitourinary Terminations
    Location: Hall C
    Presenter: Bhargava Chitti, MD – Northwell Health Center for Advanced Medicine
  • 2:30 PM - 3:45 PM ET
    3151 - Morphological Variation in Rectal Hydrogel Spacer One Month after Insertion during Low Dose Rate Brachytherapy for Prostate Adenocarcinoma
    Location: Hall C
    Presenter: Hyeok Choi, MD – Yonsei Cancer Center
  • 2:30 PM - 3:45 PM ET
    3152 - Dosimetric Comparison of Margin-Reduced CT-Guided with MRI-Guided Stereotactic Body Radiotherapy for Localized Prostate Cancer
    Location: Hall C
    Presenter: Patrick Courtney, MD, MAS – UCLA David Geffen School of Medicine/UCLA Medical Center
  • 2:30 PM - 3:45 PM ET
    3153 - Clinical and Dosimetric Outcomes of Patients Who Received Daily-Adaptive Post-Prostatectomy Salvage Radiation
    Location: Hall C
    Presenter: Michael Cummings, MD – University of Rochester Medical Center
  • 2:30 PM - 3:45 PM ET
    3154 - EQD2 Constraints for Organs at Risk in Re-Irradiation Planning for Thoracic and Head and Neck Cancers
    Location: Hall C
    Presenter: Samira Dabaghmanesh, PhD – Medical College of Wisconsin
  • 2:30 PM - 3:45 PM ET
    3155 - Evaluation of Clinical and Educational Impact of Head and Neck-Specific Chart Rounds in a High-Volume Multi-Center Integrated Health Care System
    Location: Hall C
    Presenter: Fara Dayani, MD, MS – Kaiser Permanente Los Angeles Medical Center
  • 2:30 PM - 3:45 PM ET
    3156 - Stereotactic Ablative Radiotherapy for Renal Cell Carcinomas - An Experience from a Single Center
    Location: Hall C
    Presenter: Tomás De Souza, MD – McGill University Health Centre
  • 2:30 PM - 3:45 PM ET
    3157 - Hypofractionated Intensity Modulated Radiation Therapy and Weekly Gemcitabine for Muscle Invasive Bladder Cancer. Long-Term Results
    Location: Hall C
    Presenter: Tomás De Souza, MD – McGill University Health Centre
  • 2:30 PM - 3:45 PM ET
    3158 - Impact of a Nurse Practitioner-Led Follow-Up Clinic within a Rapid-Access Palliative Radiotherapy Program for Patients with Metastatic Cancer
    Location: Hall C
    Presenter: Katherine Del poso-Lee, MSN, NP-PHC – Princess Margaret Cancer Centre
  • 2:30 PM - 3:45 PM ET
    3159 - Exploring the Role of Angiotensin Converting Enzyme Inhibitors in Genito-Urinary Toxicity Following Curative Radiotherapy for Bladder Cancer
    Location: Hall C
    Presenter: Ayo Olowofela, MD, MS – Medical College of Wisconsin
  • 2:30 PM - 3:45 PM ET
    3160 - International Harmonization of Technical Approaches to Kidney SABR - An International Radiosurgery Consortium of the Kidney (IROCK) Contouring Project
    Location: Hall C
    Presenter: Aneesh Dhar, MD, MS, FRCPC – Memorial Sloan Kettering Cancer Center
  • 2:30 PM - 3:45 PM ET
    3161 - Differential Use of Radiotherapy Fractionation Regimens for Muscle-Invasive Bladder Cancer
    Location: Hall C
    Presenter: Marshall Diven, MD – NYP/BMH
  • 2:30 PM - 3:45 PM ET
    3162 - Care Alerts for Readiness Excellence (CARE): Initiative to Reduce Symptom-Related Treatment Delays
    Location: Hall C
    Presenter: Victoria Doss, MD – Johns Hopkins Medicine
  • 2:30 PM - 3:45 PM ET
    3163 - Risk of Death in Octogenarians with Intermediate Risk Prostate Cancer Who Are Treated with Radiation Therapy (RT) Plus Androgen Deprivation Therapy (ADT) Versus Radiation Alone, an NCDB Analysis
    Location: Hall C
    Presenter: Timothy Dougherty, MD – Allegheny Health Network
  • 2:30 PM - 3:45 PM ET
    3164 - Apparent Diffusion Coefficient as an Early Prognostic Factor of Response to Treatment with Androgen Deprivation Therapy and Radiotherapy in Patients with Prostate Cancer
    Location: Hall C
    Presenter: Ana Aurora Diaz-Gavela, MD – Hospital Universitario Quiron Madrid
  • 2:30 PM - 3:45 PM ET
    3165 - Evaluating Guideline-Concordant Androgen Deprivation for High-Risk Prostate Cancer in a Statewide Quality Consortium
    Location: Hall C
    Presenter: Michael Dykstra, MD – University of Michigan
  • 2:30 PM - 3:45 PM ET
    3166 - Prostate Cancer in Southeast Asia: An Analysis of 2022 Incidence and Mortality Data
    Location: Hall C
    Presenter: Michelle Ann Eala, MD – UCLA David Geffen School of Medicine/UCLA Medical Center
  • 2:30 PM - 3:45 PM ET
    3167 - The State of Peer Review Practice in Community Radiation Oncology: Results of a National Survey of NCORP Network Sites
    Location: Hall C
    Presenter: Michael Farris, MD – Wake Forest University Medical Center
  • 2:30 PM - 3:45 PM ET
    3168 - Triage Schema for O-Ring vs. C-Arm Gantry Machine Load Balancing
    Location: Hall C
    Presenter: Seth Fehrs, MS – Emory University
  • 2:30 PM - 3:45 PM ET
    3169 - Real-World Medical Device Reports of PEG Hydrogel Spacers: Analysis of the FDA Manufacturer and User Facility Device Experience (MAUDE) Database
    Location: Hall C
    Presenter: Michael Folkert, MD, PhD – University of Washington-Fred Hutchinson Cancer Center
  • 2:30 PM - 3:45 PM ET
    3170 - Early Results from a Prospective Trial Testing Stereotactic Salvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR(NCT05455736)
    Location: Hall C
    Presenter: Giulio Francolini, MD – Azienda Ospedaliera Universitaria Careggi
  • 2:30 PM - 3:45 PM ET
    3171 - Matching Strategy on the Use of Image-Guided Hypo-Fractionated Radiotherapy for Localized Prostate Cancer
    Location: Hall C
    Presenter: Yan Gao, MS – Peking University First Hospital
  • 2:30 PM - 3:45 PM ET
    3172 - Prostate Moderate Hypo-Fractionated Radiotherapy: Urethral and Bladder Dose-Effect Relations in Genitourinary Toxicity and Dosimetric Advantages of Urinary Protection Technique
    Location: Hall C
    Presenter: Yan Gao, MS – Peking University First Hospital
  • 2:30 PM - 3:45 PM ET
    3173 - Factors Associated with Successful CT Simulation in Prostate Cancer Radiotherapy
    Location: Hall C
    Presenter: Karishma George, MD, MBBS, DNB – Tom Baker Cancer Centre / University of Calgary
  • 2:30 PM - 3:45 PM ET
    3174 - Disease Site Specific Peer Review Highlights the Need for Prospective Contour Review for Head and Neck Treatment Planning
    Location: Hall C
    Presenter: Beth Ghavidel, MS – Winship at Emory University Hospital Midtown
  • 2:30 PM - 3:45 PM ET
    3175 - Enhancing Workflow Efficiency for Managing Patients with Cardiac Implantable Electronic Devices in Radiation Oncology: A Lean Approach
    Location: Hall C
    Presenter: Beth Ghavidel, MS – Winship at Emory University Hospital Midtown
  • 2:30 PM - 3:45 PM ET
    3176 - Pattern of Failure Following Salvage Radiation Therapy after Prostatectomy
    Location: Hall C
    Presenter: Lucia Goanta, MD – Regina Elena National Cancer Institute
  • 2:30 PM - 3:45 PM ET
    3177 - International Prostate Symptom Score Outcomes of Five Different Treatment Paradigms for Localized Prostate Cancer: A Single-Institution Experience
    Location: Hall C
    Presenter: Nicholas Gravbrot, MD – University of Utah Huntsman Cancer Institute
  • 2:30 PM - 3:45 PM ET
    3178 - The Effect of Age on Clinicopathological Features and Treatment Outcomes of Patients Receiving Definitive Radiotherapy for Localized Prostate Cancer
    Location: Hall C
    Presenter: Ozan Cem Guler, MD – Baskent University
  • 2:30 PM - 3:45 PM ET
    3179 - Prostate-Specific Membrane Antigen-Directed Focal Stereotactic Radiation Therapy in Two Fractions for Locally Recurrent Prostate Cancer after Definitive Radiation Therapy
    Location: Hall C
    Presenter: Liat Hammer, MD, PhD – Sheba Medical Center
  • 2:30 PM - 3:45 PM ET
    3180 - Effect of Ethnic Concordance in Post-Treatment Follow-Up and Surveillance of Korean American Breast Cancer Patients Treated with Adjuvant Radiotherapy
    Location: Hall C
    Presenter: Hye Ri Han, MD, MS – University of Southern California/Los Angeles General Medical Center
  • 2:30 PM - 3:45 PM ET
    3181 - Clinical Workflow Evaluation of High-Performance Imaging on a C-Arm Linear Accelerator
    Location: Hall C
    Presenter: Robyn Handschuh, MS, DABR – The Ohio State University James Cancer Hospital
  • 2:30 PM - 3:45 PM ET
    3182 - Stereotactic Body Radiotherapy (SBRT) as Definitive Management for Renal Cell Carcinoma with and without Real-Time MRI Guidance
    Location: Hall C
    Presenter: Colin Harari, MD – University of Wisconsin Carbone Cancer Center
  • 2:30 PM - 3:45 PM ET
    3183 - Toxicity Comparison of Whole Pelvic vs. Prostate Only Proton Therapy - Results from the Proton Collaborative Group PCG 001-09
    Location: Hall C
    Presenter: Ananya Raghavan, BS – New York Proton Center
  • 2:30 PM - 3:45 PM ET
    3184 - A Phase Il Clinical Study of Axitinib and Toripalimab Combined with Stereotactic Radiation (SBRT) for Metastatic Renal Cell Carcinoma (mRCC) after Oligoprogression from First-Line Anti-Angiogenic Ther
    Location: Hall C
    Presenter: Lingling Cai, MB – Sun Yat-Sen University Cancer Center
  • 2:30 PM - 3:45 PM ET
    3184 - A Phase Il Clinical Study of Axitinib and Toripalimab Combined with Stereotactic Radiation (SBRT) for Metastatic Renal Cell Carcinoma (mRCC) after Oligoprogression from First-Line Anti-Angiogenic Ther
    Location: Hall C
    Presenter: Liru He, PhD – Sun Yat-Sen University Cancer Center
  • 2:30 PM - 3:45 PM ET
    3185 - Rectal Wall Infiltration with Hyaluronic Acid Based Rectal Spacer and Its Reversal
    Location: Hall C
    Presenter: Anne Hong, MD – Austin Health
  • 2:30 PM - 3:45 PM ET
    3187 - The Performance of Multiparametric MRI in Identification of Intraprostatic Tumor Deposits after Local Prostate Radiation Therapy
    Location: Hall C
    Presenter: R. Hsi, MD – University of Washington-Fred Hutchinson Cancer Center
  • 2:30 PM - 3:45 PM ET
    3188 - Mid-Term Analysis of the Combination Therapy of Axitinib, Toripalimab, and Stereotactic Ablative Body Radiotherapy (SABR) in the Treatment of Recurrent Metastatic Renal Cell Carcinoma
    Location: Hall C
    Presenter: Ke Hu, MD – Peking University First Hospital
  • 2:30 PM - 3:45 PM ET
    3189 - Outcomes of Primary Tumor Stereotactic Ablative Body Radiotherapy for Localized and Metastatic Renal Cell Carcinoma
    Location: Hall C
    Presenter: Daniel Huang, MD – University of Chicago
  • 2:30 PM - 3:45 PM ET
    3190 - Analysis of High-Volume Biopsy Core Involvement and Failure after SBRT Monotherapy for Intermediate Risk Prostate Cancer
    Location: Hall C
    Presenter: Vianca Santos, MPH – NYU Langone Health - Long Island
  • 2:30 PM - 3:45 PM ET
    3191 - Food Insecurity and Sociodemographic Influences on PSA Screening
    Location: Hall C
    Presenter: Vianca Santos, MPH – NYU Langone Health - Long Island
  • 2:30 PM - 3:45 PM ET
    3192 - Personalized Deep Learning Model for Target Volume Based on CBCT for Prostate Adaptive SBRT Patients
    Location: Hall C
  • 2:30 PM - 3:45 PM ET
    3193 - A Feasibility Study Assessed the Predictive Ability of MRI Delta-Radiomics for GU Toxicity and IPSS Changes in PCa Hypofractionated RT
    Location: Hall C
    Presenter: Haruo Inokuchi, MD, PhD – Osaka Metropolitan University Graduate School of Medicine
  • 2:30 PM - 3:45 PM ET
    3194 - Long-Term Outcomes of Image-Guided Proton Therapy with Gold Fiducial Marker for Localized Prostate Cancer
    Location: Hall C
    Presenter: Hiromitsu Iwata, MD, PhD – Nagoya City University West Medical Center
  • 2:30 PM - 3:45 PM ET
    3196 - Assessment of OpenAI-Based Chatbots Performance in Extracting Patient Consultation Information
    Location: Hall C
    Presenter: Julian Jeberaeel, DO – Detroit Medical Center/Wayne State University
  • 2:30 PM - 3:45 PM ET
    3197 - Radiation Therapy for Prostate Cancer: Baseline Platelet Count and Anti-Platelet and Anticoagulant Use Are Associated with Disease Outcomes in a Cohort of 1000 Men
    Location: Hall C
    Presenter: Stanley Liauw, MD, FASTRO – University of Chicago
  • 2:30 PM - 3:45 PM ET
    3197 - Radiation Therapy for Prostate Cancer: Baseline Platelet Count and Anti-Platelet and Anticoagulant Use Are Associated with Disease Outcomes in a Cohort of 1000 Men
    Location: Hall C
    Presenter: Matthew Ji, BS – University of Chicago
  • 2:30 PM - 3:45 PM ET
    3198 - Challenges in Developing an AI-Based Analysis System for Incident Learning
    Location: Hall C
    Presenter: Abbas Jinia, PhD – Memorial Sloan Kettering Cancer Center
  • 2:30 PM - 3:45 PM ET
    3199 - Artificial Intelligence Model Using PSMA PET Imaging of Primary Prostate Cancer for Analyzing Metastases and Post-Treatment Progression
    Location: Hall C
    Presenter: Jesus Juarez Casillas, MD, MS – UCLA
  • 2:30 PM - 3:45 PM ET
    3200 - Beating the Clock: An Audit of Time Taken to Deliver Swallowing Sparing IMRT for Head and Neck Carcinoma
    Location: Hall C
    Presenter: Yousra Izzuddeen KN, MD, MBBS, DNB – All India Institute of Medical Sciences
  • 2:30 PM - 3:45 PM ET
    3201 - Demographic differences between consenting versus non-consenting participants for biospecimen collection on NRG prostate cancer trials
    Location: Hall C
    Presenter: Sophia Kamran, MD – Massachusetts General Hospital
  • 2:30 PM - 3:45 PM ET
    3202 - Patterns of Leukopenia in Men with Prostate Cancer Receiving Definitive Pelvic Irradiation
    Location: Hall C
    Presenter: Ari Kassardjian, MD – City of Hope Comprehensive Cancer Center
  • 2:30 PM - 3:45 PM ET
    3203 - A Prospective Study of Stereotactic Body Radiotherapy in Oligometastatic Renal Cell Carcinoma
    Location: Hall C
    Presenter: Rohan Katipally, MD – University of Chicago Medical Center
  • 2:30 PM - 3:45 PM ET
    3204 - Intermediate Term Urinary Outcomes Following Prostate Radiation Therapy after Neoadjuvant Prostate Artery Embolization
    Location: Hall C
    Presenter: Vaseem Khatri, MD – Moffitt Cancer Center
  • 2:30 PM - 3:45 PM ET
    3205 - Psmaddition: Phase 3 Trial of [177lu]Lu-PSMA-617 Plus Standard of Care (SoC) vs. Soc Alone in Patients with Metastatic Hormone-Sensitive Prostate Cancer
    Location: Hall C
    Presenter: Hyun Kim, MD – Washington University School of Medicine in St. Louis
  • 2:30 PM - 3:45 PM ET
    3206 - Context-Dependent Impact of Tumor-Infiltrating B Cells in High-Risk Prostate Cancer and Head and Neck Cancer
    Location: Hall C
    Presenter: Sangwoo Kim, MD – University of California, San Diego
  • 2:30 PM - 3:45 PM ET
    3207 - Inter- and Intra-Observer Variability in Catheter Localization in High-Dose-Rate Brachytherapy for Prostate Cancer with Stepping Transverse and Twister Sagittal Volume Scanning
    Location: Hall C
    Presenter: Soo Kyoung Kim, MD – UC Davis Cancer Center
  • 2:30 PM - 3:45 PM ET
    3208 - Acute Toxicity and Quality of Life in Postoperative Prostate Cancer Patients Treated with Ultra-Hypofractionated Pelvic Radiation Therapy
    Location: Hall C
    Presenter: Isidora King, MD – Clinica IRAM
  • 2:30 PM - 3:45 PM ET
    3209 - Oncologic Outcomes of Upfront Radiation Therapy vs. Surgery, while Accounting for Intraprostatic Tumor Volume
    Location: Hall C
    Presenter: Martin King, MD, PhD – Brigham and Womens Hospital
  • 2:30 PM - 3:45 PM ET
    3210 - 18F-Flotufolastat Detection Rates in the Pelvis Region for Patients with Prostate Cancer Recurrence after Radical Prostatectomy and PSA Levels <1 ng/mL: Data from the Phase 3 SPOTLIGHT S
    Location: Hall C
    Presenter: Bridget Koontz, MD, FASTRO – AdventHealth Cancer Institute
  • 2:30 PM - 3:45 PM ET
    3211 - Association of MRI Capsular Involvement and Extraprostatic Extension on Metastasis Free and Overall Survival in Localized Prostate Cancer Treated with Radiation
    Location: Hall C
    Presenter: Abhishek Kumar, MD, MAS – Duke Cancer Institute
  • 2:30 PM - 3:45 PM ET
    3212 - Radiation Induced Lymphopenia Depends on Lymph Node Irradiation in Prostate Cancer Radiotherapy
    Location: Hall C
    Presenter: Lukasz Kuncman, MD, PhD – Fundacja im Jakuba Hrabiego Potockiego
  • 2:30 PM - 3:45 PM ET
    3213 - Efficacy of Oligometastasis Directed Stereotactic Body Radiation Therapy in De Novo Oligometastatic Prostate Cancer
    Location: Hall C
    Presenter: Dominic LaBella, MD – Thomas Jefferson University
  • 2:30 PM - 3:45 PM ET
    3214 - Efficacy of Oligorecurrence Directed Stereotactic Body Radiation Therapy in Oligorecurrent Prostate Cancer
    Location: Hall C
    Presenter: Dominic LaBella, MD – Thomas Jefferson University
  • 2:30 PM - 3:45 PM ET
    3215 - A Secondary Analysis of Radiotherapy Oncology Group (RTOG/NRG) Trials 9202, 9413, and 9910: Unknown Causes of Death and Their Impact on Prostate Cancer Specific Mortality Estimates
    Location: Hall C
    Presenter: Joan Lee, MD – University Hospitals Cleveland Medical Center
  • 2:30 PM - 3:45 PM ET
    3216 - Feasibility of PSMA PET-Assisted MR-Guided Radiotherapy for Prostate Cancer Patients Treated with Curative Aim
    Location: Hall C
    Presenter: Joon-gyo Lee, MD – Gachon University Gil Medical Center
  • 2:30 PM - 3:45 PM ET
    3217 - Prognostic Value of Central Gland Volume on MRI for Biochemical Recurrence after Prostate Cancer Radiotherapy
    Location: Hall C
    Presenter: Joseph Lee, MD, PhD – Corewell Health William Beaumont University Hospital
  • 2:30 PM - 3:45 PM ET
    3218 - Decoding Cancer Radiotherapy Discontinuation: A Comprehensive Analysis
    Location: Hall C
    Presenter: Huei Fang Yang, BS, RN – Chung Shan Medical University Hospital
  • 2:30 PM - 3:45 PM ET
    3219 - Apparent Diffusion Coefficient Tumor Volume is the Most Prognostic Radiomic Feature in Localized Prostate Cancer
    Location: Hall C
    Presenter: Jonathan Leeman, MD – Brigham and Women's Hospital/Dana-Farber
  • 2:30 PM - 3:45 PM ET
    3221 - The Effectiveness of Radiotherapy for Upper Tract Urothelial Carcinoma (UTUC) with Lymph Node Metastasis and Optimal Target Delineation for Clinical Target Volume
    Location: Hall C
    Presenter: Xiaoying Li, MD – Peking University First Hospital
  • 2:30 PM - 3:45 PM ET
    3222 - Impact of Hyaluronic Acid (HA) Rectal Spacer Quality Score (SQS) and Fischer-Valuck (FV) Spacer Symmetry Score on Rectal Dosimetry and Acute and Late Gastrointestinal (GI) Toxicity Outcomes - An Austr
    Location: Hall C
    Presenter: Yuan-Hong Lin, MD – Alfred Health
  • 2:30 PM - 3:45 PM ET
    3223 - Rectal Spacer Impact on MRI-Directed SBRT Prostate Microboost in Concert with Pelvic Nodal Irradiation
    Location: Hall C
    Presenter: Jonathan Lischalk, MD – New York University Perlmutter Cancer Center
  • 2:30 PM - 3:45 PM ET
    3225 - Exploring Gene Expression and Pathway Analysis in Localized Prostate Cancer: Insights from a Retrospective Cohort Study with a Focus on Hypoxia and Angiogenic Biomarkers Post-EBRT and HDR-BTb
    Location: Hall C
    Presenter: Taha Lodhi, MB, ChB – The Christie NHS Foundation Trust
  • 2:30 PM - 3:45 PM ET
    3226 - A Randomized Controlled Study of a New Model of Symptom Management Based on PRO in Patients with Head and Neck Tumors Receiving Radiotherapy
    Location: Hall C
    Presenter: Xiaoli Long
  • 2:30 PM - 3:45 PM ET
    3227 - A Prospective Cohort Study Assessing Patient Reported Outcomes after Post-Prostatectomy Radiation Therapy: Longer-Term Follow-Up through 5 Years
    Location: Hall C
    Presenter: Connor Lynch, MD – University of Chicago
  • 2:30 PM - 3:45 PM ET
    3228 - Impact of Posterior PTV Margin on the Treatment Efficiency and Adverse Effects of Radical Radiotherapy for Prostate Cancer Patients
    Location: Hall C
    Presenter: Lin Ma, MD – Peking University First Hospital
  • 2:30 PM - 3:45 PM ET
    3229 - A Prospective Cohort Study Evaluating the Efficacy and Safety of Adjuvant Chemotherapy in High-Risk Non-Metastatic Prostate Cancer Patients with High Gleason Scores
    Location: Hall C
    Presenter: Ming-Wei Ma, MD – Peking University First Hospital
  • 2:30 PM - 3:45 PM ET
    3230 - Patterns of Care and Associated Socioeconomic Determinants of Health in the Definitive Treatment of Localized Muscle-Invasive Bladder Cancer Patients
    Location: Hall C
    Presenter: Megan Mai, MPH – Texas Tech University Health Science Center
  • 2:30 PM - 3:45 PM ET
    3231 - Adaptive-Driven CT Simulation Free SBRT Workflow Validation and Initial Experience
    Location: Hall C
    Presenter: Victor Malkov, PhD, MCCPM – Mayo Clinic Rochester
  • 2:30 PM - 3:45 PM ET
    3232 - Estimating Life Expectancy prior to Curative Intent Prostate Radiation Therapy in Underserved Patient Populations
    Location: Hall C
    Presenter: Swati Mamidanna, MD – Rutgers Cancer Institute of New Jersey
  • 2:30 PM - 3:45 PM ET
    3233 - Evaluation of an Artificial Intelligence-Based Software for Adaptative Radiotherapy in Head and Neck Cancer Treatments
    Location: Hall C
    Presenter: Pauline Maury, PhD – Institut Gustave Roussy
  • 2:30 PM - 3:45 PM ET
    3234 - Peer Review as a Means of Improvement and Harmonization of Treatment Plans Among a Multinational Radiation Oncology Team
    Location: Hall C
    Presenter: Basma Mbarek, MD – far east medical
  • 2:30 PM - 3:45 PM ET
    3235 - Bladder Neck Dosimetry and Interfractional Variation in Proton Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer
    Location: Hall C
    Presenter: Hamilton McGinnis, MD – Emory University School of Medicine
  • 2:30 PM - 3:45 PM ET
    3236 - Hyaluronic Acid Rectal Spacer in Locally Recurrent Prostate Cancer with Prior Radiation Receiving SBRT: A Report on Feasibility, Safety and Toxicity
    Location: Hall C
    Presenter: LaToya McLean, MD, MS, BS – Thomas Jefferson University
  • 2:30 PM - 3:45 PM ET
    3237 - Magnetic Resonance-Guided Stereotactic Body Radiotherapy for Metastatic Renal Cell Carcinoma
    Location: Hall C
    Presenter: Elie Mehanna, MD – Harvard Radiation Oncology Program
  • 2:30 PM - 3:45 PM ET
    3238 - Reducing Patient Safety Risk with the Implementation of Intradepartmental Survey Program across a Multi-Site Large Teaching Institution
    Location: Hall C
    Presenter: Timothy Meier, RT, (R)(T) – Cleveland Clinic
  • 2:30 PM - 3:45 PM ET
    3239 - Radiotherapy is a Treatment Option for Cancer in the Very Old (80+):  A Single Institution Experience
    Location: Hall C
    Presenter: Oliver Micke, MD – Franzikus Hospital Bielefeld
  • 2:30 PM - 3:45 PM ET
    3240 - Uptake and Positivity Rates of PSMA PET Staging for Newly Diagnosed Prostate Cancer in a National Healthcare System
    Location: Hall C
    Presenter: Sean Miller, MD – University of Michigan
  • 2:30 PM - 3:45 PM ET
    3241 - Radiotherapy Treatment with Radical Doses in De Novo Low Burden Metastatic Prostate Cancer: Early Outcomes Report.
    Location: Hall C
  • 2:30 PM - 3:45 PM ET
    3242 - Respecting Patients Privacy Rights and Medical Data Safety at a Radiation Oncology Department during Remote Consultations and Surveillance
    Location: Hall C
    Presenter: Miroslawa Mocydlarz-Adamcewicz, PhD – Wielkopolskie Centrum Onkologii
  • 2:30 PM - 3:45 PM ET
    3243 - Testosterone Recovery and Associated Impact on Patient-Reported Health-Related Quality of Life (HRQoL) after Treatment with 6 Months of GnRH Agonist with or without Abiraterone Acetate plus Prednisone
    Location: Hall C
    Presenter: Shalini Moningi, MD – Brigham and Women's Hospital/Dana-Farber
  • 2:30 PM - 3:45 PM ET
    3244 - A Randomized Phase II Trial of High Dose-Rate (HDR) and Low Dose-Rate (LDR) Brachytherapy as Monotherapy in Localized Prostate Cancer: Analysis of Initial Arms of Canadian Cancer Trials Group PR19 (NC
    Location: Hall C
    Presenter: Gerard Morton, MD – Sunnybrook Health Sciences Centre
  • 2:30 PM - 3:45 PM ET
    3245 - Correlation of Circulating Tumor DNA (ctDNA) Dynamics with Clinical Response in Muscle-Invasive Bladder Cancer (MIBC) Patients Undergoing Trimodality Therapy (TMT)
    Location: Hall C
    Presenter: Kent Mouw, MD, PhD – Dana-Farber/Brigham and Women's Cancer Center
  • 2:30 PM - 3:45 PM ET
    3246 - Customized Electronic Quality Checklists to Reduce Errors and Improve Radiotherapy Workflow
    Location: Hall C
    Presenter: Hussam Hijazi, MD, MB, BS, MBBS – King Abdulaziz University
  • 2:30 PM - 3:45 PM ET
    3247 - Comparison of Local Medicare Guidance and Medicare Advantage Plans for Stereotactic Radiosurgery for Brain Metastases
    Location: Hall C
    Presenter: Trey Mullikin, MD – Duke Cancer Institute
  • 2:30 PM - 3:45 PM ET
    3248 - Biochemical Recurrence is Not a Surrogate for Overall Survival in Localized Prostate Cancer: Data from 2 Phase III Trials
    Location: Hall C
    Presenter: Abdenour Nabid, MD – CHUS
  • 2:30 PM - 3:45 PM ET
    3249 - Quality of Life and Weight Variation during Androgen Deprivation Therapy in Patients with High-Risk Prostate Cancer: Long-Term Data from a Phase III Trial
    Location: Hall C
    Presenter: Abdenour Nabid, MD – CHUS
  • 2:30 PM - 3:45 PM ET
    3250 - Phase 2 Prospective Trial of Re-Treatment with 177lu-PSMA-617 Molecular Radiotherapy for Metastatic Castration Resistant Prostate Cancer (RE-LuPSMA): Study Protocol
    Location: Hall C
    Presenter: John Nikitas, MD – UCLA Radiation Oncology
  • 2:30 PM - 3:45 PM ET
    3251 - Treatment Terminations in Gynecological Malignancies
    Location: Hall C
    Presenter: Jason Nosrati, MD – Montefiore Einstein Cancer Center
  • 2:30 PM - 3:45 PM ET
    3252 - Comparison of Decipher vs. Oncotype (GPS) Genomic Profiling Scores in NCCN Intermediate Risk Prostate Cancer Patients
    Location: Hall C
    Presenter: Edward Obedian, MD – The Cancer Institute at St. Francis Hospital
  • 2:30 PM - 3:45 PM ET
    3253 - The Safety and Efficacy of Lutetium-177-PSMA-617 Therapy for Metastatic CRPC in a Real World Community Cancer Center
    Location: Hall C
    Presenter: Edward Obedian, MD – The Cancer Institute at St. Francis Hospital
  • 2:30 PM - 3:45 PM ET
    3254 - Investigating the Machine Learning-Derived Nomogram Models and Biomarkers for Side-Specific Prediction of Extraprostatic Extension of Prostate Cancer - Preliminary Results
    Location: Hall C
    Presenter: Oluwaseyi Oderinde, PhD – Purdue University
  • 2:30 PM - 3:45 PM ET
    3255 - Stereotactic Body Radiotherapy with Hydrogel Spacer for Prostate Cancer: 5-Year Follow-Up Results of a Phase 2 Trial
    Location: Hall C
    Presenter: Mami Ogita, MD, PhD – University of Tokyo Hospital
  • 2:30 PM - 3:45 PM ET
    3256 - Treatment Outcomes of External Beam Radiotherapy with or without Focal Boost to Intraprostatic Lesions in Patients with Localized Prostate Cancer
    Location: Hall C
    Presenter: Huseyin Cem Onal, MD – Baskent University Faculty of Medicine
  • 2:30 PM - 3:45 PM ET
    3257 - Impact of Definitive Radiotherapy on Metabolic Response Measured with 68Ga-PSMA-PET/CT in Patients with Intermediate-Risk Prostate Cancer
    Location: Hall C
    Presenter: Huseyin Cem Onal, MD – Baskent University Faculty of Medicine
  • 2:30 PM - 3:45 PM ET
    3258 - Study on the Focal Boost to the Dominant Intraprostatic Lesions Using Proton Therapy in High-Risk Prostate Cancer Patients with Pelvic Lymph Node Irradiation: Assessing Toxicity Using the Accumulated
    Location: Hall C
    Presenter: Ashley Ong, PhD, CMD – National Cancer Centre Singapore
  • 2:30 PM - 3:45 PM ET
    3259 - Financial Difficulties and Long-Term Oncological Outcomes Following Prostate Radiotherapy and Androgen Deprivation Therapy - Post-Hoc Analyses of TROG0304/ RADAR Trial
    Location: Hall C
    Presenter: Wee Loon Ong, MBBS – Alfred Health Radiation Oncology
  • 2:30 PM - 3:45 PM ET
    3260 - Preoperative Intraprostatic Tumor Volume Is Prognostic for Metastasis after Early Salvage Post-Prostatectomy Radiation Therapy
    Location: Hall C
    Presenter: James Parisi, BS – Brigham and Womens Hopsital
  • 2:30 PM - 3:45 PM ET
    3261 - Brachytherapy Deserts in Texas: Assessment of Geographic Availability of Brachytherapy Centers
    Location: Hall C
    Presenter: Mayank Patel, MD, MBA – University of Miami
  • 2:30 PM - 3:45 PM ET
    3262 - Failure Patterns of Bladder Only Hypofractionated Radiation with Gemcitabine in Muscle Invasive Bladder Cancer (MIBC)
    Location: Hall C
    Presenter: Abigail Pepin, MD – University of Pennsylvania Health System
  • 2:30 PM - 3:45 PM ET
    3263 - Prospective Analysis on Tumor Control, Survival, Toxicity and Quality of Life Outcomes of an HDR-Brachytherapy Boost for Prostate Cancer
    Location: Hall C
    Presenter: Max Peters, RT – Radiotherapiegroep Arnhem
  • 2:30 PM - 3:45 PM ET
    3264 - Ultra-Short-Course Hormone Therapy for Intermediate Risk Prostate Cancer Treated with Definitive Radiotherapy: Retrospective Analysis of a National Healthcare System
    Location: Hall C
    Presenter: Alex Bryant, MD, MS – University of Michigan
  • 2:30 PM - 3:45 PM ET
    3265 - PSMA-PET Radiopharmaceutical Image Scoring Method (PRISM): A Practical Tool for Predicting 177lu-PSMA-617 Therapy Outcomes in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
    Location: Hall C
    Presenter: Hyma Polimera, MD – Penn State Cancer Institute
  • 2:30 PM - 3:45 PM ET
    3266 - Estimating Risk of Biochemical Recurrence after RT Utilizing a Convolutional Neural Network
    Location: Hall C
    Presenter: Martin King, MD, PhD – Brigham and Womens Hospital
  • 2:30 PM - 3:45 PM ET
    3267 - Implementation of a Patient Tracking Whiteboard for Prospective Peer Review in a Community-Based Radiation Oncology Program
    Location: Hall C
    Presenter: Malolan Rajagopalan, MD, MBA – Mount Carmel Health System
  • 2:30 PM - 3:45 PM ET
    3268 - Radiation Chronotherapy in Prostate Cancer: Does Time of Day of Radiation Treatment Influence Disease Outcome or Symptom Burden?
    Location: Hall C
    Presenter: Greeshma Rajeev-Kumar, MD – University of Chicago Medicine
  • 2:30 PM - 3:45 PM ET
    3269 - PSMA MRI Guided Prostate SBRT: Acute Toxicity and Early Results from the ARGOS-Climber Phase I/II Trial
    Location: Hall C
    Presenter: Sherif Ramadan, MD – Western University
  • 2:30 PM - 3:45 PM ET
    3270 - Microboost and Dosimetric Variability in Localized Prostate Cancer: Analysis of a Prospective Statewide Quality Collaborative
    Location: Hall C
    Presenter: Samuel Regan, MD – University of Michigan
  • 2:30 PM - 3:45 PM ET
    3271 - Metastasis-Free Survival after Adjuvant or Salvage Radiation Therapy Following Radical Prostatectomy in a National Healthcare Delivery System
    Location: Hall C
    Presenter: Samuel Regan, MD – University of Michigan
  • 2:30 PM - 3:45 PM ET
    3272 - Postoperative Hypofractionated Radiotherapy for Prostate Cancer: Results of a Large Cohort
    Location: Hall C
    Presenter: Xue-Ying Ren, MD – Peking University First Hospital
  • 2:30 PM - 3:45 PM ET
    3273 - Impact of PSMA PET-CT Findings on Dose Prescription and Target Definition in Patients with Biochemical Relapse after Radical Prostatectomy
    Location: Hall C
    Presenter: Christoph Resl, MD – UK Krems an der Donau
  • 2:30 PM - 3:45 PM ET
    3274 - Prostate Salvage Brachytherapy Utilization and Efficacy over Two Decades at a Single Institution
    Location: Hall C
    Presenter: Daniel Rosen, MD, PhD – Harvard Radiation Oncology Program
  • 2:30 PM - 3:45 PM ET
    3275 - Automated Template-Based Planning and Prostate Stereotactic Body Radiotherapy without Real-Time Seed-Tracking: A Regional Service Experience
    Location: Hall C
    Presenter: Amie Ross, RT – Mid North Coast Cancer Institute (MNCCI) Coffs Harbour
  • 2:30 PM - 3:45 PM ET
    3277 - Association of Absolute Amount of Pattern 4 Disease on Prostate Biopsy with Oncologic Outcomes in Intermediate-Risk Prostate Cancer: A Systematic Review
    Location: Hall C
    Presenter: Melissa Sam Soon, BHSc – University of Ottawa
  • 2:30 PM - 3:45 PM ET
    3278 - A Phase 2/3 Study of 177Lu-TLX591 Plus SOC vs. SOC Alone in Patients with Metastatic Castration-Resistant Prostate Cancer (ProstACT GLOBAL)
    Location: Hall C
    Presenter: Divya Madhu, PharmD – Telix Pharmaceuticals
  • 2:30 PM - 3:45 PM ET
    3279 - Safety Profile of High-Dose Intensity Modulated Radiotherapy in Prostate Cancer: Preliminary Findings from the JROSG 17-5 Multicenter Prospective Observational Study in Japan
    Location: Hall C
    Presenter: Yuta Sekino, MD, PhD – University of Tsukuba
  • 2:30 PM - 3:45 PM ET
    3280 - Multi-Class Prediction Using Machine Learning to Predict Pathologic Stage in Prostate Cancer
    Location: Hall C
  • 2:30 PM - 3:45 PM ET
    3281 - Hypofractionated vs. Conventionally Fractionated Radiotherapy for Prostate Cancer: A Meta-Analysis of Randomized Trials
    Location: Hall C
    Presenter: Parvez Shaikh, MD, ScB MScHI – West Virginia University School of Medicine
  • 2:30 PM - 3:45 PM ET
    3282 - Clinical Efficacy of Localized Salvage Prostate Cancer Retreatments Using CBCT-Guided Proton Scanning Beams with Over 2-Year Follow-Ups
    Location: Hall C
    Presenter: Charles Shang, MB, MS – South Florida Proton Therapy Institute
  • 2:30 PM - 3:45 PM ET
    3283 - Telemedicine Use in Older Adults with Cancer Presenting for Radiation Oncology Consultation
    Location: Hall C
    Presenter: Yasamin Sharifzadeh, MD – Mayo Clinic Rochester
  • 2:30 PM - 3:45 PM ET
    3284 - Patient Reported Outcomes in Radiotherapy (PRO-RT) Utilizing an Integrated Patient Portal; Results from a Prospective Single Arm Trial
    Location: Hall C
    Presenter: Yasamin Sharifzadeh, MD – Mayo Clinic Rochester
  • 2:30 PM - 3:45 PM ET
    3285 - Dosimetric Comparison between Adaptation Strategies for MRI-Guided Dose-Intensified Prostate Stereotactic Ablative Radiotherapy
    Location: Hall C
    Presenter: Julia Shi, BS – University of Texas Southwestern Medical Center
  • 2:30 PM - 3:45 PM ET
    3286 - High Risk Prostate Cancer Treated with Radiation Therapy: Favorable Outcomes in Men with PSA>20 as the Sole High Risk Factor
    Location: Hall C
    Presenter: Stanley Liauw, MD, FASTRO – University of Chicago
  • 2:30 PM - 3:45 PM ET
    3287 - Comparison of Urethra Morphology on CT with Urinary Catheter and MRI without Urinary Catheter after Low Dose Rate Prostate Cancer Brachytherapy
    Location: Hall C
    Presenter: Ingrid Sidibe, MD – CHU de Quebec - Universite Laval - Centre integre de cancerologie
  • 2:30 PM - 3:45 PM ET
    3288 - Moderately Hypofractionated Proton Therapy with or without Implantable Spacer in Patients with Localized Prostate Cancer
    Location: Hall C
    Presenter: Soborun Kaviraj, MD – Universitatsklinikum Dresden Klinik f Strahlentherapie und Radioonkologie
  • 2:30 PM - 3:45 PM ET
    3289 - Veterans Affairs seamless phase II/III randomized trial of STAndard systemic theRapy with or without PET-directed local therapy for Oligometastatic pRosTate cancer (VA STARPORT)
    Location: Hall C
    Presenter: Abhishek Solanki, MD, MS – Loyola University Chicago Stritch School of Medicine
  • 2:30 PM - 3:45 PM ET
    3290 - Practice Patterns of Primary Stereotactic Radiotherapy for Renal Cell Carcinoma in the United States
    Location: Hall C
    Presenter: Yash Soni, MD, BS – UT Southwestern Medical Center
  • 2:30 PM - 3:45 PM ET
    3291 - National Use of PEG Hydrogel Spacer for Men with Prostate Cancer in the U.S. over Six Years
    Location: Hall C
    Presenter: Daniel Spratt, MD – University Hospitals Seidman Cancer Center
  • 2:30 PM - 3:45 PM ET
    3292 - Radiotherapy vs. Radical Prostatectomy in Patients with Intraductal Carcinoma of the Prostate
    Location: Hall C
    Presenter: Taylor Stamey, MOP – East Carolina University Brody School of Medicine
  • 2:30 PM - 3:45 PM ET
    3293 - Impact of Nutritional Status and Therapy on Survival among Radiotherapy Patients: A Study of a Chinese Population
    Location: Hall C
    Presenter: Yue Su, MD – Sichuan Cancer Hospital
  • 2:30 PM - 3:45 PM ET
    3294 - A Comprehensive Evaluation of an Independent Quality Assurance System for Intensity Modulated Proton Therapy Treatment Plans and Deliveries
    Location: Hall C
    Presenter: Zhong Su, PhD, MBA – University of Arkansas for Medical Sciences College of Medicine
  • 2:30 PM - 3:45 PM ET
    3295 - Implications of Rectal Wall Gel Placement in Treatment Delay
    Location: Hall C
    Presenter: Grace Sun, MD, BS – Michigan Medicine
  • 2:30 PM - 3:45 PM ET
    3296 - Hypoxia-Guided Dose Escalated Radiation Therapy in Prostate Cancer: A Dosimetric Feasibility Study
    Location: Hall C
    Presenter: Dorine de Jong, PhD – RefleXion
  • 2:30 PM - 3:45 PM ET
    3297 - Progression Free Survival Prediction for Oligometastatic Renal Cell Cancer Patients after Stereotactic Ablative Radiation Therapy
    Location: Hall C
    Presenter: Shanshan Tang, PhD – UT Southwestern Medical Center
  • 2:30 PM - 3:45 PM ET
    3298 - Predicting Chemoradiotherapy Induced Cardiotoxicity in Breast Cancer Patients Using Machine Learning Based Clinical, Imaging and Dosimetric Radiomics Features
    Location: Hall C
    Presenter: Beth Ghavidel, MS – Winship at Emory University Hospital Midtown
  • 2:30 PM - 3:45 PM ET
    3299 - Organ at Risk Dose Constraints in Conventionally Fractionated Pelvic Radiation Therapy: A Systematic Review of Clinical Trials
    Location: Hall C
    Presenter: Leila Tchelebi, MD – Northern Westchester Hospital
  • 2:30 PM - 3:45 PM ET
    3300 - Per-Fraction Analysis of PTV Margin Reduction and Organ Dose Optimization for Intact Prostate
    Location: Hall C
    Presenter: Diego Toesca, MD – Mayo Clinic Arizona
  • 2:30 PM - 3:45 PM ET
    3301 - A Phase 4 Open-Label Multicenter Study of Piflufolastat F 18 PET/CT or PET/MRI in Men with Newly Diagnosed Favorable Intermediate Risk Prostate Cancer: MIRROR
    Location: Hall C
    Presenter: Jonathan Tward, MD, PhD, FASTRO – University of Utah
  • 2:30 PM - 3:45 PM ET
    3302 - Comparison of Perirectal Spacer Placement Quality during the Learning Curve for 3 FDA Approved Products
    Location: Hall C
    Presenter: Jonathan Tward, MD, PhD, FASTRO – University of Utah
  • 2:30 PM - 3:45 PM ET
    3303 - Treatment Outcomes with Neoadjuvant Chemotherapy Followed by Chemoradiation for Muscle Invasive Bladder Cancer
    Location: Hall C
    Presenter: Melissa Usoz, MS, BS – Prisma Health Cancer Institute
  • 2:30 PM - 3:45 PM ET
    3304 - A Pilot Study of Immunological Response to PSMA-Directed Radioligand Therapy for the Treatment of Oligometastatic Prostate Cancer
    Location: Hall C
    Presenter: Luca Valle, MD – UCLA Radiation Oncology
  • 2:30 PM - 3:45 PM ET
    3305 - Physician Assessment and Clinical Evaluation of the Suitability of Deep Learning Based Auto Segmentation Contours for Organs at Risk Delineation in Radiation Oncology
    Location: Hall C
    Presenter: Sarah Way, MS – Minneapolis Radiation Oncology PA
  • 2:30 PM - 3:45 PM ET
    3306 - Assessing Bilateral Neurovascular Bundles Function with Pulsed Wave Doppler Ultrasound: Implications for Reducing Erectile Dysfunction Following Prostate Radiotherapy
    Location: Hall C
    Presenter: Tian Liu, PhD – Icahn School of Medicine at Mount Sinai
  • 2:30 PM - 3:45 PM ET
    3307 - Efficacy of an Adaptive Plan Quality Predictor for Decision Support in Online MR-Guided Adaptive Radiotherapy for Prostate Stereotactic Ablative Radiotherapy
    Location: Hall C
    Presenter: Siqiu Wang, PhD – University of Texas Southwestern Medical Center
  • 2:30 PM - 3:45 PM ET
    3308 - Daily Online Adaptive Radiotherapy for Rectal Cancer Utilizing CT-Linac: Assessing Feasibility, Toxicities and Optimal Margins
    Location: Hall C
    Presenter: Weiping Wang, MD, PhD – Peking Union Medical College Hospital
  • 2:30 PM - 3:45 PM ET
    3309 - Factors Associated with Completion of Treatment Course with Lutetium-177 Vipivotide Tetraxetan in Men with Metastatic Castration-Resistant Prostate Cancer at a Single Institution
    Location: Hall C
    Presenter: Peter Whatts, MD – Detroit Medical Center/Wayne State University
  • 2:30 PM - 3:45 PM ET
    3310 - Characterizing Failure after Trimodality Therapy in Bladder Cancer: A Retrospective Analysis of Clinical, Spatial and Dosimetric Factors
    Location: Hall C
    Presenter: Matthew Whitmill, MD – UNC Health
  • 2:30 PM - 3:45 PM ET
    3311 - Baseline Characteristics of Patients Enrolled on the Prostate Advanced Radiation Technologies Investigating Quality of Life (PARTIQoL) Trial Comparing Proton Therapy vs. IMRT for Low or Intermediate R
    Location: Hall C
    Presenter: Jason Efstathiou, MD, PhD, FASTRO – Massachusetts General Hospital
  • 2:30 PM - 3:45 PM ET
    3312 - The Broader Impact of Specialized Outpatient Cancer Rehabilitation on Functioning and Health Outcomes during Radiation Treatment
    Location: Hall C
    Presenter: Kelley Wood, PhD, MS – Select Medical
  • 2:30 PM - 3:45 PM ET
    3313 - Dosimetric Study of Dose De-Escalation Using MRI-Guidance in Low and Intermediate Risk Prostate Cancer Patients with Pd-103 Low Dose Rate Brachytherapy
    Location: Hall C
    Presenter: Lin Wang, MS – Northwell Health
  • 2:30 PM - 3:45 PM ET
    3314 - Multivariate Analysis of Pretreatment Biomarkers Predicting Treatment Completion in Patients Undergoing Lu-177-PSMA-617 Radiopharmaceutical Therapy
    Location: Hall C
    Presenter: Edmond Yaghoubian, MD – UPMC
  • 2:30 PM - 3:45 PM ET
    3315 - Predictive Factors for Oliogometastatic Renal Cell Carcinoma Patients Treated with Stereotactic Ablative Radiation (SAbR)
    Location: Hall C
    Presenter: Joseph Kwon, MD
  • 2:30 PM - 3:45 PM ET
    3316 - HDR Brachytherapy Boost for Unfavorable Localized Prostate Cancer: A Single Center Experience from Inception to Standard of Care
    Location: Hall C
    Presenter: Juanita Crook, MD – BCCancer
  • 2:30 PM - 3:45 PM ET
    3317 - Calculation of Dose Perturbations Caused by 2 mm of Intraprostatic Calcification for Permanent Prostate Seed Implant Using Pd103 in Excel/Python
    Location: Hall C
    Presenter: Ashraf Youssef, MD, MBA – Our Lady of Lourdes Memorial Hospital Inc.
  • 2:30 PM - 3:45 PM ET
    3319 - Caring for the Carers: Factors Associated with Perceived Burden among Caregivers of Filipino Cancer Patients Undergoing Radiation Therapy in Two Tertiary Care Hospitals in the Philippines
    Location: Hall C
    Presenter: Jose Ma. Zaldarriaga, MD, MBA – St. Luke's Medical Center
  • 2:30 PM - 3:45 PM ET
    3322 - Analysis of Theranostic 177Lu-PSMA-617 Therapy Efficacy and Toxicity in Patients with Advanced Prostate Cancer
    Location: Hall C
    Presenter: Anthony Zhang, BS – UCONN Health Center
  • 2:30 PM - 3:45 PM ET
    3323 - Failure Modes and Effects Analysis Applied to Total Body Irradiation
    Location: Hall C
    Presenter: Hongjun Zhang, PhD – Atrium Health Levine Cancer Institute
  • 2:30 PM - 3:45 PM ET
    3324 - A Novel Six-Zone Method to Guide Delineation of Clinical Target Volume (CTV) for Postoperative Radiotherapy of Prostate Cancer, Based on the Distribution of Prostate Bed Recurrence by PSMA PET
    Location: Hall C
    Presenter: Simone Deng, PhD – Peking University First Hospital
  • 2:30 PM - 3:45 PM ET
    3325 - Long-Term Outcomes of SAbR for Metastatic RCC
    Location: Hall C
    Presenter: Lucian Zhao, MD, BS – UT Southwestern Medical Center
  • 2:30 PM - 3:45 PM ET
    3326 - Impact of CT Online Adaptive Radiotherapy on Acute Toxicity in Patients Undergoing Prostate Radiotherapy
    Location: Hall C
    Presenter: Lin Zhu, MD, PhD – Harvard Radiation Oncology Program
  • 2:30 PM - 3:45 PM ET
    3327 - Analysis of the Treatment Planning Quality Assurance Reports for Intensity Modulated Proton Therapy at an Established Proton Center
    Location: Hall C
    Presenter: Mingyao Zhu, PhD – Emory University School of Medicine
  • 2:30 PM - 3:45 PM ET
    3328 - Optimizing Rectal Dose and Minimizing Toxicity in Prostate Radiotherapy in a Randomized Pivotal Trial: Assessment of Rectal Spacer Placement Effect on Rectal Dosimetry and Toxicity
    Location: Hall C
    Presenter: Vishesh Agrawal, MD – Advanced Radiation Centers of New York
  • 4:00 PM - 5:00 PM ET
    3329 - Prognostic Value of Quantitative PET/CT Parameters in Large B-Cell Lymphoma Patients Following CAR T-Cell Therapy Failure
    Location: Hall C
    Presenter: Chirayu Patel, MD, MD, MPH – Massachusetts General Hospital
  • 4:00 PM - 5:00 PM ET
    3330 - Multi-Institutional Update on Bridging Radiotherapy in Relapsed or Refractory Large B-Cell Lymphoma Patients Prior to CAR T-Cell Therapy
    Location: Hall C
    Presenter: Chirayu Patel, MD, MD, MPH – Massachusetts General Hospital
  • 4:00 PM - 5:00 PM ET
    3331 - Long-Term Outcomes of Surface Applicator Brachytherapy in the Management of Cutaneous Lymphomas: A 20 Year Single Institutional Experience
    Location: Hall C
    Presenter: Chirayu Patel, MD, MD, MPH – Massachusetts General Hospital
  • 4:00 PM - 5:00 PM ET
    3332 - Assessing ChatGPTs Utility as an Educational Aid for Cancer Patients Undergoing Radiation Therapy
    Location: Hall C
    Presenter: Sami Abi Farraj, MD – Hotel-Dieu de France University Hospital
  • 4:00 PM - 5:00 PM ET
    3333 - Predicting Absolute Risk of First Relapse in Classical Hodgkin Lymphoma by Incorporating Contemporary Treatment Effects
    Location: Hall C
    Presenter: Berthe Aleman, MD, PhD – Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL)
  • 4:00 PM - 5:00 PM ET
    3334 - Artificial Intelligence for Identification of Radiation-Related Toxicities from the Electronic Health Records of Patients with Head and Neck Cancer
    Location: Hall C
    Presenter: Faisal Alfadli, MB, ChB – University of Toronto
  • 4:00 PM - 5:00 PM ET
    3335 - Genome-Wide Cell-Free DNA Fragmentation Analyses for Early, Non-Invasive Detection of Treatment Response to Standard of Care Adjuvant Radiation Treatment in High-Grade Gliomas
    Location: Hall C
    Presenter: Akshaya Annapragada, MS, BA – Johns Hopkins University School of Medicine
  • 4:00 PM - 5:00 PM ET
    3336 - Development of Machine Learning Algorithms from Computed Tomography Images to Predict Catastrophic Airway Events in Patients with Cancers in the Aerodigestive Tract
    Location: Hall C
    Presenter: Hannah Bacon, MD, PhD – University of Toronto
  • 4:00 PM - 5:00 PM ET
    3337 - Dosimetric Predictors of Radiation Pneumonitis in Locally Advanced Non-Small Cell Lung Cancer Patients with Artificial-Intelligence Screened Interstitial Lung Disease
    Location: Hall C
    Presenter: Hannah Bacon, MD, PhD – University of Toronto
  • 4:00 PM - 5:00 PM ET
    3338 - Left Ventricular Sphericity as a Radiomic Predictor of Cardiac Outcomes after Thoracic Radiotherapy for Lung Cancer
    Location: Hall C
    Presenter: Mina Bakhtiar, MD – Mass General Brigham/Massachusetts General Hospital/Harvard Med School
  • 4:00 PM - 5:00 PM ET
    3339 - Validation of Multi-Modal Artificial Intelligence Biomarker for Predicting Biochemical Recurrence in Patients with Prostate Cancer Undergoing Prostatectomy
    Location: Hall C
    Presenter: Atallah Baydoun, MD, PhD – Case Western Reserve University
  • 4:00 PM - 5:00 PM ET
    3340 - Identifying Cancer Recurrence from the Electronic Medical Record: Using Natural Language Processing to Interpret Pathology Reports
    Location: Hall C
    Presenter: Diego Bayona – Mayo Clinic Alix School of Medicine
  • 4:00 PM - 5:00 PM ET
    3341 - Utilizing Large Language Models for Enhanced Clinical Trial Matching
    Location: Hall C
    Presenter: Jacob Beattie
  • 4:00 PM - 5:00 PM ET
    3342 - Using Large Language Models to Create Patient Centered Consent Forms
    Location: Hall C
    Presenter: Jacob Beattie
  • 4:00 PM - 5:00 PM ET
    3343 - Performance of Large Language Models on the Radiation and Cancer Biology Practice Exam
    Location: Hall C
    Presenter: Jessica Bertschmann, MD, MS, BS – University of Alberta
  • 4:00 PM - 5:00 PM ET
    3344 - Multi-Cancer Early Detection Utilizing Blood-Based Genomics: Single-Institution Case Series of Novel Cancer Screening
    Location: Hall C
    Presenter: Jason Burton, MD, PhD – Oregon Health and Science University
  • 4:00 PM - 5:00 PM ET
    3345 - Patterns of Intracranial Response and Relapse after Radiotherapy for Patients with Chemorefractory or Progressive Secondary CNS Lymphoma
    Location: Hall C
    Presenter: Gustav Cederquist, MD, PhD – Memorial Sloan Kettering Cancer Center
  • 4:00 PM - 5:00 PM ET
    3346 - Decoding Patient Heterogeneity Influencing Radiation-Induced Brain Necrosis
    Location: Hall C
    Presenter: Ibrahim Chamseddine, PhD – Massachusetts General Hospital, Harvard Medical School
  • 4:00 PM - 5:00 PM ET
    3347 - The Impact of Standard vs. Hypofractionated Total Skin Electron Beam Therapy (TSE) on Cytopenias in Mycosis Fungoides/Sezary Syndrome (MF/SS)
    Location: Hall C
    Presenter: Monica Chelius, MD – University of Pennsylvania
  • 4:00 PM - 5:00 PM ET
    3348 - Radiation in Combination with Bispecific Therapy Does Not Suggest Excess Toxicity in B-Cell Lymphomas
    Location: Hall C
    Presenter: Monica Chelius, MD – University of Pennsylvania
  • 4:00 PM - 5:00 PM ET
    3349 - Uncertainty Estimation in Radiotherapy Dose Prediction with Deep Learning for Head and Neck Cancers
    Location: Hall C
    Presenter: Liting Chen
  • 4:00 PM - 5:00 PM ET
    3350 - Segmon and Dosemon: Synergistic In-House Innovations Transforming Radiotherapy Workflow
    Location: Hall C
    Presenter: Arnold Pompos, PhD – University of Texas Southwestern Medical Center
  • 4:00 PM - 5:00 PM ET
    3352 - Multi-Channel 3D Convolutional Neural Network to Predict Grade 2 Xerostomia Following Definitive Radiation for Head and Neck Squamous Cell Carcinoma
    Location: Hall C
    Presenter: Kai-Cheng Chuang, PhD, MS – Duke University Medical Center
  • 4:00 PM - 5:00 PM ET
    3353 - Impact of Deep Learning Auto Segmentation Accuracy on Duodenal Dose-Volume Parameters for Pancreas SBRT Patients Treated with MR-Guided Online Adaptive Radiotherapy
    Location: Hall C
    Presenter: Asma Amjad, PhD – Medical College of Wisconsin
  • 4:00 PM - 5:00 PM ET
    3354 - Delineation of Primary Lung Cancer with Atelectasis Assisted by GANs-Based Synthetic PET Images from CT
    Location: Hall C
    Presenter: Baiqiang Dong, MD, PhD – Sun Yat-Sen University Cancer Center
  • 4:00 PM - 5:00 PM ET
    3355 - Radiation Therapy (RT) in a New Era of Multiple Myeloma (MM) Therapy: Trends of Engagement and Radiologic, Biochemical, and Cytogenetic Correlates of Outcomes and Response
    Location: Hall C
    Presenter: Alexandra Dreyfuss, MD, MS – Memorial Sloan Kettering Cancer Center
  • 4:00 PM - 5:00 PM ET
    3356 - Early Experience with Salvage RT for Relapsed / Refractory Multiple Myeloma Following BCMA-Directed CAR T Cell Therapy
    Location: Hall C
    Presenter: Alexandra Dreyfuss, MD, MS – Memorial Sloan Kettering Cancer Center
  • 4:00 PM - 5:00 PM ET
    3357 - Failure Patterns by PET for Relapsed / Refractory Multiple Myeloma (r/r MM) after CAR T Cell Therapy: Potential Role for Radiotherapy (RT)?
    Location: Hall C
    Presenter: Alexandra Dreyfuss, MD, MS – Memorial Sloan Kettering Cancer Center
  • 4:00 PM - 5:00 PM ET
    3358 - Benchmarking OpenAI ChatGPT and Google Bard on Radiation Physics Study Exams (RAPHEX) and Implication for Their Use as a Learning Tool
    Location: Hall C
    Presenter: Tomas Dvorak, MD – Orlando Health
  • 4:00 PM - 5:00 PM ET
    3359 - A Novel Interactive Online Visualizer for Clinical Trial Data
    Location: Hall C
    Presenter: Michelle Ann Eala, MD – UCLA David Geffen School of Medicine/UCLA Medical Center
  • 4:00 PM - 5:00 PM ET
    3360 - Proton Pencil Beam Scanning Facilitates Safe Treatment of Extended Radiation Targets for Hodgkin Lymphoma: A Report from the Proton Collaborative Group Registry
    Location: Hall C
    Presenter: Maryam Ebadi, MD – University of Washington
  • 4:00 PM - 5:00 PM ET
    3361 - AI Generated Clinical Target Volumes for Oropharyngeal Cancers Using a General Foundation Model
    Location: Hall C
    Presenter: Sharif Elguindi, MS – Memorial Sloan Kettering Cancer Center
  • 4:00 PM - 5:00 PM ET
    3362 - In-Depth Timing Study of AI-Assisted OAR Contouring with a Single Institution Expert
    Location: Hall C
    Presenter: Sharif Elguindi, MS – Memorial Sloan Kettering Cancer Center
  • 4:00 PM - 5:00 PM ET
    3363 - Automated Extraction of PSA Values from Unstructured Medical Records with a Large Language Model for Cancer
    Location: Hall C
    Presenter: Nicholas Eustace, MD, PhD – City of Hope National Medical Center
  • 4:00 PM - 5:00 PM ET
    3364 - Treatment Response and Risk of Local Recurrence after Radiotherapy in Patients with Plasma Cell Neoplasms
    Location: Hall C
    Presenter: Agnes Ewongwo, MD – Stanford University
  • 4:00 PM - 5:00 PM ET
    3365 - Bridging Radiotherapy prior to Brexucabtagene Autoleucel for Relapsed/Refractory Mantle Cell Lymphoma
    Location: Hall C
    Presenter: Ahmed Fetooh, MD – MD Anderson Cancer Center
  • 4:00 PM - 5:00 PM ET
    3366 - Radiotherapy Outcomes in Solitary Plasmacytoma with High Risk Cytogenetic Abnormalities
    Location: Hall C
    Presenter: Kelsey Frechette, MD – Mayo Clinic College of Medicine and Science Rochester
  • 4:00 PM - 5:00 PM ET
    3367 - Radiation Therapy for Oligo-Relapsed/Progressive Disease Post-Stem Cell Transplant for Multiple Myeloma: Factors Associated with Favorable Outcomes
    Location: Hall C
    Presenter: Beatrice Fregonese, MPH – Memorial Sloan Kettering Cancer Center
  • 4:00 PM - 5:00 PM ET
    3368 - Standardization of Treatment Protocols for Multi-Center Institutional Health Systems
    Location: Hall C
    Presenter: Sandeepan Ganguly, MS – Montefiore Medical Center/Albert Einstein College of Medicine
  • 4:00 PM - 5:00 PM ET
    3369 - Treatment Outcome, Toxicity and Quality of Life of Patients with Bronchus-Associated Lymphoid Tissue Lymphoma
    Location: Hall C
    Presenter: Lin-rui Gao, MD – Chinese Academy of Medical Sciences and Peking Union Medical College
  • 4:00 PM - 5:00 PM ET
    3370 - Biological - Physical Model of Human Glioma Cells Based on Microdosimetry
    Location: Hall C
    Presenter: Yunan Gao, MS – Zhongshan Hospital Fudan University
  • 4:00 PM - 5:00 PM ET
    3371 - Using a Large Language Model (LLM) for Automated Extraction of Discrete Elements from Clinical Notes for Creation of Cancer Databases
    Location: Hall C
    Presenter: Marissa Gilbert, BS – Henry Ford Hospital
  • 4:00 PM - 5:00 PM ET
    3372 - A CD8 T Cell Radiomics Score Correlates with Local Failure in Patients Undergoing Combined SBRT and Immune Checkpoint Inhibition in a Pooled Analysis of Three Phase I Trials
    Location: Hall C
    Presenter: Naomi Goldrich, MD – University of Chicago
  • 4:00 PM - 5:00 PM ET
    3373 - Using High-Repeatable Radiomic Features Improves the Cross-Institutional Generalization of Prognostic Model in Esophageal Cancer Receiving Definitive Chemoradiotherapy
    Location: Hall C
    Presenter: Jie Gong, PhD – Life Sciences Research Center, School of Life Sciences and Technology, Xidian University,
  • 4:00 PM - 5:00 PM ET
    3374 - Pathology AI for Risk Stratification (PAIRS): Predicting Adverse Pathological Features in Post-Operative Head and Neck Cancer with Large Language Models
    Location: Hall C
    Presenter: Jace Grandinetti, PhD – University of Pennsylvania
  • 4:00 PM - 5:00 PM ET
    3375 - Quantitative and Qualitative Evaluation of an Automated Planning Solution for Prostate Radiotherapy
    Location: Hall C
    Presenter: William Green, MD – University of Pennsylvania
  • 4:00 PM - 5:00 PM ET
    3376 - Reconstructing Active Bone Marrow Dose in a Large-Scale Study on Clonal Hematopoiesis and Leukemia Risk Following Radiotherapy
    Location: Hall C
    Presenter: Keith Griffin, PhD – National Cancer Institute
  • 4:00 PM - 5:00 PM ET
    3377 - Spatially Fractionated Radiation Therapy (SFRT) Based on Multimodal Imaging: A Promising Salvage Treatment Strategy for Metastatic and Refractory Cancer Patients
    Location: Hall C
    Presenter: Y.X. Guo, MD – Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
  • 4:00 PM - 5:00 PM ET
    3378 - The Impact of Radiotherapy on Survival Outcomes in Plasmablastic Lymphoma
    Location: Hall C
    Presenter: Philip Haddad, MD, MPH, MHA – LSU Health Sciences Center Shreveport
  • 4:00 PM - 5:00 PM ET
    3381 - Impact of a Pre-Treatment Electronic Frailty Index on Survival, Treatment Completion and Hospitalization in Patients Treated with Radiotherapy
    Location: Hall C
    Presenter: Ryan Hughes, MD – Wake Forest University School of Medicine
  • 4:00 PM - 5:00 PM ET
    3382 - Hype or Reality: Utility of Large Language Models in Radiation Oncology
    Location: Hall C
    Presenter: Brian Jang, MD – University of Minnesota
  • 4:00 PM - 5:00 PM ET
    3383 - Enhancing Adaptive Radiotherapy with Dynamic Prescription Modifications
    Location: Hall C
    Presenter: Phillip Jenkins, DO, MS – Detroit Medical Center/Wayne State University
  • 4:00 PM - 5:00 PM ET
    3384 - Lost in Lunglation: Unraveling the Mystery of Idiopathic Pulmonary Syndrome Post-Total Body Irradiation for Bone Marrow Transplant
    Location: Hall C
    Presenter: Ruijia Jin, MS4 – University of British Columbia
  • 4:00 PM - 5:00 PM ET
    3385 - Uncertainty Quantification in Machine Learning Radiotherapy Applications - A Scoping Review
    Location: Hall C
    Presenter: Zaphanlene Kaffey, MS – UT MD Anderson Cancer Center
  • 4:00 PM - 5:00 PM ET
    3386 - Utility of Analytics in a Large Community-Based Radiation Oncology Network: Consolidation and Standardization of Clinical, Operational and Quality Metrics
    Location: Hall C
    Presenter: Andrew Kennedy, MD, FACRO – Sarah Cannon Cancer Center at TriStar Health
  • 4:00 PM - 5:00 PM ET
    3387 - Local Disease Control in Patients with Erdheim-Chester Disease Treated with External Beam Radiation Therapy
    Location: Hall C
    Presenter: Adam Kessel, MD – Mayo Clinic Rochester
  • 4:00 PM - 5:00 PM ET
    3388 - A Novel Localized Student-Teacher LLM for Enhanced Toxicity Extraction in Radiation Oncology
    Location: Hall C
    Presenter: Reza Khanmohammadi, MS – Michigan State University
  • 4:00 PM - 5:00 PM ET
    3389 - Improving Intestinal Crypt Detection in Deep Learning Models with Reinhard Method-Based Stain Color Normalization for Evaluating Normal Tissue Radiation Response
    Location: Hall C
    Presenter: Matthew Kim, BS – Stanford University School of Medicine
  • 4:00 PM - 5:00 PM ET
    3390 - Treatment of Patients with Gastric Extranodal Marginal Zone Lymphomas (MZL) Using CBCT-based Adaptive Radiotherapy (ART) to Reduce Margins
    Location: Hall C
    Presenter: Kiran Kumar, MD, MBA – UT Southwestern Medical Center
  • 4:00 PM - 5:00 PM ET
    3391 - Multi-Omics Models can Predict Prostate Specific Membrane Antigen Avidity for Computed Tomography Lesions in Oligo-Metastatic Castration Sensitive Prostate Cancer
    Location: Hall C
    Presenter: Ritesh Kumar, MD – Rutgers Cancer Institute of New Jersey
  • 4:00 PM - 5:00 PM ET
    3392 - Trends in Radiation Fractionation for Early-Stage Follicular or Marginal Zone Lymphoma
    Location: Hall C
    Presenter: Raymond Zou, BA – City of Hope National Medical Center
  • 4:00 PM - 5:00 PM ET
    3393 - Optimizing Radiation Oncology: Integrating Clinical Decision Support and Automated Treatment Planning for Enhanced Quality, Consistency and Efficiency
    Location: Hall C
    Presenter: Kieu Lai, RT – GenesisCare
  • 4:00 PM - 5:00 PM ET
    3394 - Ultra-Low-Dose Adaptive Radiotherapy and Single-Agent Rituximab for Indolent Non-Hodgkin Lymphomas: Where Less is More in Combined Modality Therapy
    Location: Hall C
    Presenter: Katherine Lake, BA – UT Southwestern Medical School
  • 4:00 PM - 5:00 PM ET
    3395 - A Simple Walking Program to Enhance Concurrent Chemoradiotherapy Delivery: A Randomized Trial
    Location: Hall C
    Presenter: Travis Lambert, MD – Montefiore Medical Center/Albert Einstein College of Medicine
  • 4:00 PM - 5:00 PM ET
    3396 - Enhancing Charge Capture Accuracy in Radiation Oncology: A Comprehensive Software Analysis
    Location: Hall C
    Presenter: Christel Smith, PhD – Fuse Oncology, Inc.
  • 4:00 PM - 5:00 PM ET
    3397 - Auto-Segmentation of Elective Nodal Clinical Target Volumes for Anal Cancer Using Artificial Intelligence
    Location: Hall C
    Presenter: Bryant Law, BS – UC Davis School of Medicine
  • 4:00 PM - 5:00 PM ET
    3398 - A Comparison of Machine Learning Models to Predict Lymph Node Metastasis with Primary Tumor Transcriptome in Non-Small Cell Lung Cancer
    Location: Hall C
    Presenter: Victor Lee, MD, BS – Yale New Haven Hospital
  • 4:00 PM - 5:00 PM ET
    3399 - Value of Peritumoral Radiomics in Predicting Local Recurrence-Free Survival in Esophageal Squamous Cell Carcinoma Receiving Definitive (Chemo)Radiotherapy
    Location: Hall C
    Presenter: Jie Li
  • 4:00 PM - 5:00 PM ET
    3400 - Implementing Proton Beam Therapy for Mediastinal Lymphoma
    Location: Hall C
    Presenter: Suganya Sivabalasingham, MBBS, BSc MRCP FRCR MD(Res) – University College London Hospitals NHS Trust
  • 4:00 PM - 5:00 PM ET
    3401 - Research on Developing a Predictive Model for Radiation Pneumonitis Risk Based on Radiomics and Multiparameters
    Location: Hall C
    Presenter: Yi Li, MD – The 920th Hospital of The Joint Logistic Support Forth
  • 4:00 PM - 5:00 PM ET
    3402 - Accurate Response Prediction of Locally Advanced Rectal Cancer: A Novel Radiomic Framework Utilizing Virtual Rectum-Unfolding in Multiparametric MR Images
    Location: Hall C
    Presenter: Zi Rong Li, BS
  • 4:00 PM - 5:00 PM ET
    3403 - Enhancing Precision in Automated Segmentation of Ambiguous Boundaries Based on Multi-Model Deep Learning and Boundary Confidence Computation
    Location: Hall C
    Presenter: Zi Rong Li, BS
  • 4:00 PM - 5:00 PM ET
    3404 - Deep Learning-Based Fully Automated Detection and Segmentation of Lymph Nodes on Computed Tomography for Head and Neck Cancer: A Multi-Center Study
    Location: Hall C
    Presenter: Wenjun Liao, PhD
  • 4:00 PM - 5:00 PM ET
    3405 - Evaluation of Deep Learning-Based Abdominal Organ Segmentation Models: Assessing Robustness across Non-Surgery to Organ Resection Surgery Patients
    Location: Hall C
    Presenter: Wenjun Liao, PhD
  • 4:00 PM - 5:00 PM ET
    3406 - Deep Learning with Biopsy Whole Slide Images for Predicting Pathological Complete Response to Neoadjuvant Immunochemotherapy in Esophageal Squamous Cell Carcinoma
    Location: Hall C
    Presenter: Charlotte Zhao – Manteia Technologies
  • 4:00 PM - 5:00 PM ET
    3407 - Assessing the Current Clinical Application of ChatGPT-4 in Radiation Oncology
    Location: Hall C
    Presenter: Yen-Ting Liu, MD – National Taiwan University
  • 4:00 PM - 5:00 PM ET
    3408 - Prometheus: A Risk Classification Deep Learning Model for Predicting Liver Metastases from Pancreatic Cancer
    Location: Hall C
    Presenter: Yirong Liu, MD, PhD – Northwestern Memorial Hospital
  • 4:00 PM - 5:00 PM ET
    3409 - Multimodality Deep Learning Radiomics Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy
    Location: Hall C
    Presenter: Yunsong Liu, MD – National Cancer Center/National Clinical Research Center for Cancer Cancer Hospital, CAMS & PUMC
  • 4:00 PM - 5:00 PM ET
    3410 - Tumor Response to Induction Chemotherapy Followed by Radiotherapy, Chemotherapy Intensity, and Patients with Early-Stage Extranodal Natural Killer/T Cell Lymphoma
    Location: Hall C
    Presenter: Huang Luo, MD – Chongqing University Cancer Hospital
  • 4:00 PM - 5:00 PM ET
    3411 - Construction and Selection of the Automatic Segmentation Tools for High-Risk Clinical Tumor Volume in Brachytherapy for Cervical Cancer Based on Deep Learning
    Location: Hall C
    Presenter: Chenying Ma, MD, PhD – The First Affiliated Hospital of Soochow University
  • 4:00 PM - 5:00 PM ET
    3412 - The Directive Application: Enhancing Clinical Workflow and Transforming Oncology Care with Centralized Data Management
    Location: Hall C
    Presenter: Yijian Cao, PhD – Northwell Health
  • 4:00 PM - 5:00 PM ET
    3413 - Applying Language Models to Radiology Text for Identifying Oligometastatic Non-Small Cell Lung Cancer
    Location: Hall C
    Presenter: Nicholas Moore, MD – Yale School of Medicine
  • 4:00 PM - 5:00 PM ET
    3414 - Radiotherapy for Marginal Zone Lymphoma of Mucosal Associated Lymphoid Tissue (MALT) Involving the Dura
    Location: Hall C
    Presenter: Zachary Moore, MD, PhD – Memorial Sloan Kettering Cancer Center
  • 4:00 PM - 5:00 PM ET
    3415 - Cancer Treatment Information Differences by Bilingual Prompting in Large Language Model Chatbots
    Location: Hall C
    Presenter: Javier Mora, MD – Harvard Radiation Oncology Program
  • 4:00 PM - 5:00 PM ET
    3416 - Multiomic Based Bayesian Network Toxicity Modeling for Simultaneous Prediction of Multiple Toxicity Outcomes in NSCLC
    Location: Hall C
    Presenter: Saurabh Nair, MSc – The university of Texas M. D. Anderson Cancer Center
  • 4:00 PM - 5:00 PM ET
    3417 - Patterns of CNS Failures in Relapse/Refractory Large B-Cell Lymphoma (LBCL) Patients with Secondary CNS Disease Following Chimeric Antigen Receptor T-Cell (CAR T) Therapy
    Location: Hall C
    Presenter: Justyn Nakashima, DO – Moffitt Cancer Center
  • 4:00 PM - 5:00 PM ET
    3418 - National Cancer Trial Network (NCTN) Gynecologic Trial Mentions across Physician Facing Platforms
    Location: Hall C
    Presenter: Neethi Narasimha, BS – Edward Via College of Osteopathic Medicine
  • 4:00 PM - 5:00 PM ET
    3419 - Feasibility of Determining Heterogenous Risk Regions Using Dual Tree Wavelet Based Radiomics for Rectal Cancer Patients during MRgART
    Location: Hall C
    Presenter: Haidy Nasief, MS, PhD, MSCE – Froedtert and Medical College of Wisconsin
  • 4:00 PM - 5:00 PM ET
    3420 - A Machine-Learning Model to Predict Axillary Node Positivity from Clinical Characteristics and Large-Scale DNA Organization Features in Breast Cancer Biopsy Specimens
    Location: Hall C
    Presenter: Alan Nichol, MD, FRCPC – BC Cancer - Vancouver Centre
  • 4:00 PM - 5:00 PM ET
    3421 - Developing Blood Sparing Radiotherapy Following CAR T for Lymphoma
    Location: Hall C
    Presenter: Georgios Ntentas, DPhil – Guy's and St Thomas' NHS Foundation Trust
  • 4:00 PM - 5:00 PM ET
    3422 - Comparison of Physician vs. Software Assessed Cosmetic Sores Following Breast Conservation Therapy
    Location: Hall C
    Presenter: Anna Okabe, BS – California Northstate University College of Medicine
  • 4:00 PM - 5:00 PM ET
    3423 - Objective and Interpretable Breast Cosmesis Evaluation with Attention Guided Denoising Diffusion Anomaly Detection Model
    Location: Hall C
    Presenter: Sangjoon Park, MD, PhD – Yonsei University Health System
  • 4:00 PM - 5:00 PM ET
    3424 - Can Language Models Extract Features from Pathology Reports and Stage Tumors like a Physician?
    Location: Hall C
    Presenter: Rafe McBeth, PhD
  • 4:00 PM - 5:00 PM ET
    3425 - TMI Utilization in Second Allo-SCT for Hematologic Malignancies: Update on Mucositis and Outcomes
    Location: Hall C
    Presenter: Brandon Perez, MD – University of Chicago Medicine
  • 4:00 PM - 5:00 PM ET
    3426 - Prior Knowledge Based Neural Representation Learning for Patient-Specific Imaging Study
    Location: Hall C
    Presenter: Lianli Liu, PhD – Stanford University
  • 4:00 PM - 5:00 PM ET
    3427 - Evaluating ChatGPTs Competency in Radiation Oncology: A Comprehensive Assessment across Clinical Scenarios
    Location: Hall C
    Presenter: Sherif Ramadan, MD – Western University
  • 4:00 PM - 5:00 PM ET
    3428 - Validation of Known Radiomics Biomarkers for Post-Treatment Local Response for SBRT-Treated NSCLC, Using Machine Learning
    Location: Hall C
    Presenter: Gemini Ramasamy, MS – McGill University
  • 4:00 PM - 5:00 PM ET
    3429 - Balancing Prevalence of Contrast and Non-Contrast Computed Tomography Examples in a Limited Set and Training Transformer-Based Great Vessel Segmentation
    Location: Hall C
    Presenter: Chloe Choi, MS – Memorial Sloan Kettering Cancer Center
  • 4:00 PM - 5:00 PM ET
    3430 - Quantitative and Qualitative Evaluation of an Automatic and Manual GTV Contouring Tool in Pre-Radiotherapy MRI in Glioblastoma Treatment
    Location: Hall C
    Presenter: Charlotte Robert, MD, PhD – Gustave Roussy Institute
  • 4:00 PM - 5:00 PM ET
    3431 - Implementing AI Based Radiation Therapy Workflow Management Platform
    Location: Hall C
    Presenter: Doori Rose, MS – Memorial Sloan Kettering Cancer Center
  • 4:00 PM - 5:00 PM ET
    3432 - Artificial Intelligence in Oncologic Radiotherapy: A New Tool for Treatment Selection in Patients with Early Stage Breast Cancer
    Location: Hall C
    Presenter: Agustin Rosich, MD – UDELAR Radioterapia
  • 4:00 PM - 5:00 PM ET
    3433 - A Deep Learning-Based Method for Predicting Out-of-Field Radiotherapy Dose for Pediatric Wilms Tumor Patients
    Location: Hall C
    Presenter: Monjoy Saha, PhD – National Cancer Institute (NCI)
  • 4:00 PM - 5:00 PM ET
    3434 - Independent Validation and Performance Comparison of Published Radiation Pneumonitis NTCP Models for IMRT, Immunotherapy and Proton Therapy Cohorts
    Location: Hall C
    Presenter: Ramon Salazar, PhD – University of Texas MD Anderson Cancer Center
  • 4:00 PM - 5:00 PM ET
    3435 - Adaptive Radiation Fractionation in Head and Neck Cancer through Modeling Tumor Volume Dynamics
    Location: Hall C
    Presenter: Emmanuel Scott, MD, BS – Moffitt Cancer Center
  • 4:00 PM - 5:00 PM ET
    3436 - Medical Accuracy of Cancer Radiotherapy-Related ChatGPT AI Outputs in English and Spanish
    Location: Hall C
    Presenter: Paranjay Sharma, Medical Student – University of Missouri - Kansas City
  • 4:00 PM - 5:00 PM ET
    3437 - Synthesis of Lung CT to Proton CT Based on CycleGAN
    Location: Hall C
    Presenter: Cong Sheng, MS
  • 4:00 PM - 5:00 PM ET
    3438 - Implementation of a Clinically Integrated Authorization Automation Software to Decrease Prior-Authorization Burden across a Geography of Payers
    Location: Hall C
    Presenter: William Chen, MD – Northwell Health
  • 4:00 PM - 5:00 PM ET
    3439 - External Validation of an Artificial Intelligence Screening Tool for Interstitial Lung Disease in Patients Receiving Lung Stereotactic Ablative Radiotherapy
    Location: Hall C
    Presenter: Vivian Tan, MD – London Health Sciences Centre
  • 4:00 PM - 5:00 PM ET
    3440 - Current Use and Perspectives of Artificial Intelligence in Radiation Oncology: A Statewide Consortium Survey
    Location: Hall C
    Presenter: Amina Tanweer, BS – University of Michigan Medical School
  • 4:00 PM - 5:00 PM ET
    3441 - Patient-Facing Electronic Medical Record Care Companion for Breast Cancer Patient-Reported Outcomes and Education during Radiation Therapy
    Location: Hall C
    Presenter: Sewit Teckie, MD, MBA – New York City Health and Hospitals
  • 4:00 PM - 5:00 PM ET
    3442 - Responsible Artificial Intelligence in Radiation Oncology
    Location: Hall C
    Presenter: Ching-Ling Teng, PhD – Northwell Health Center for Advanced Medicine
  • 4:00 PM - 5:00 PM ET
    3443 - Machine Learning to Predict Genomic Risk Score/Classification in Prostate Cancer
    Location: Hall C
    Presenter: Eemon Tizpa, MS – Elson S. Floyd College of Medicine Washington State University
  • 4:00 PM - 5:00 PM ET
    3444 - The Association of Consolidation Strategies with Cerebral Atrophy in Primary Central Nervous System Lymphoma (PCNSL)
    Location: Hall C
    Presenter: Kathryn Tringale, MD, MS – UC San Diego
  • 4:00 PM - 5:00 PM ET
    3445 - Testing a Predictive AI/AutoML Based Nomogram for HDR Prostate Brachytherapy
    Location: Hall C
    Presenter: Birjoo Vaishnav, PhD, DABR – Mayo Clinic College of Medicine and Science Rochester
  • 4:00 PM - 5:00 PM ET
    3446 - Multi-Institutional Qualitative Evaluation of Automatic and Manual Segmentations of Organs at Risk on PRE ACT Breast Cancer Cohorts
    Location: Hall C
    Presenter: Karolien Verhoeven, MD, PhD – MAASTRO Clinic
  • 4:00 PM - 5:00 PM ET
    3447 - Physicians Views on Explainable Artificial Intelligence Models to Predict the Risk of Toxicity Following Breast Radiotherapy
    Location: Hall C
    Presenter: Karolien Verhoeven, MD, PhD – MAASTRO Clinic
  • 4:00 PM - 5:00 PM ET
    3448 - Radiation to Sites of Skeletal Involvement in Large B-Cell Lymphoma: Trends and Impact on Survival
    Location: Hall C
    Presenter: Kim Vo, DO, MS, BS – City of Hope Comprehensive Cancer Center
  • 4:00 PM - 5:00 PM ET
    3449 - Analysis of Dual-Energy CT (DECT) Parameters in Patients with Stage I Non-Small Cell Lung Cancer Treated with Stereotactic Ablative Body Radiation (SABR) in a Prospective Study
    Location: Hall C
    Presenter: Emily Vonderhaar Meister, MD, PhD – Johns Hopkins Hospital
  • 4:00 PM - 5:00 PM ET
    3450 - Interpretable Artificial Intelligence to Predict Treatment Response in Rectal Cancer
    Location: Hall C
    Presenter: Xiang-Bo Wan
  • 4:00 PM - 5:00 PM ET
    3451 - Genetic Subclones Identify Phenotypic Variation in Diffuse Large B cell Lymphoma
    Location: Hall C
    Presenter: Boya Wang, PhD – UNC Chapel Hill School of Medicine
  • 4:00 PM - 5:00 PM ET
    3452 - Fine-Tuning Large Language Models for Radiation Oncology, A Specialized Health Care Domain
    Location: Hall C
    Presenter: Wei Liu, PhD, MS, BS, FAAPM – Mayo Clinic
  • 4:00 PM - 5:00 PM ET
    3453 - Patterns of Locoregional Recurrence and Prognosis in Early-Stage Natural Killer/T-Cell Lymphoma after Chemotherapy with Sandwiched Radiotherapy: A Post Hoc Analysis of a Randomized Controlled Clinical
    Location: Hall C
    Presenter: Shubei Wang, MD – Ruijin Hospital, Shanghai Jiaotong University School of Medicine
  • 4:00 PM - 5:00 PM ET
    3454 - Treatment and Survival in Early-Stage MALT Lymphoma: A Retrospective Study of Outcomes at a Single Institution
    Location: Hall C
    Presenter: Xinyue Wang, MD – Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
  • 4:00 PM - 5:00 PM ET
    3455 - MRI-Guided Real-Time Adaptive Radiotherapy for Liver with Deep Learning
    Location: Hall C
    Presenter: Ran Wei, PhD
  • 4:00 PM - 5:00 PM ET
    3456 - Should We Enter Orders and Prescriptions at Consult Time
    Location: Hall C
    Presenter: Benjamin Sintay, PhD – Cone Health Cancer Center
  • 4:00 PM - 5:00 PM ET
    3457 - A Comparative Study of Large Language Models for Generating Summaries of Breast Cancer Patient-Reported Treatment Toxicities
    Location: Hall C
    Presenter: David Wu, MD – Stanford Cancer Institute Palo Alto
  • 4:00 PM - 5:00 PM ET
    3458 - Validated Supervised Deep Learning on Pathology Whole-Slide Images for HER2 Mutation Prediction in Lung Adenocarcinoma
    Location: Hall C
    Presenter: Yiyue Xu, PhD – Shandong Tumor Hospital
  • 4:00 PM - 5:00 PM ET
    3459 - Artificial Intelligence-Derived Software Improves Efficiency and Reduces Costs in Radiation Oncology Research
    Location: Hall C
    Presenter: Ted Yanagihara, MD, PhD – University of North Carolina
  • 4:00 PM - 5:00 PM ET
    3460 - Utilization of FCDenseNet for Auto-Contouring in Radiation Therapy for Companion Animals
    Location: Hall C
    Presenter: Ha-Yeong Yoon, MS – Oncosoft
  • 4:00 PM - 5:00 PM ET
    3462 - A Framework to Create and Validate Synthetic Datasets for Survival Prediction in Radiation Oncology
    Location: Hall C
    Presenter: Constantinos Zamboglou, MD, PhD – German Oncology Center
  • 4:00 PM - 5:00 PM ET
    3463 - Semi-Automated Topic Identification for Radiation Oncology Safety Event Reports Using Natural Language Processing and Statistical Models
    Location: Hall C
    Presenter: Qian Zhang, MD, PhD, MS – McGaw Medical Center of Northwestern University
  • 4:00 PM - 5:00 PM ET
    3464 - Machine Learning-Based Quantification and Classification of Fibroblasts in Gastrointestinal Cancer
    Location: Hall C
    Presenter: Zhen Zhang, MD, PhD – Fudan University Shanghai Cancer Center
  • 4:00 PM - 5:00 PM ET
    3465 - Feasibility of a New Paradigm: Patient-Driven Radiation Therapy Using Smart-Phone Photogrammetry
    Location: Hall C
    Presenter: Eric Paulson, PhD – Medical College of Wisconsin
  • 4:00 PM - 5:00 PM ET
    3466 - Delineation of Tumor Metabolic Volume in Nasopharyngeal Carcinoma on Computed Tomography Images Using a 3D U-Net Model
    Location: Hall C
    Presenter: Guan-Qun Zhou, MD, PhD – Sun Yat-Sen University Cancer Center
  • 4:00 PM - 5:00 PM ET
    3467 - Trends in First-Line Use of Radiation Therapy for Early-Stage Gastric Marginal Zone Lymphoma
    Location: Hall C
    Presenter: David Zitser, BS
  • 4:00 PM - 5:00 PM ET
    3468 - Optimizing Deep Learning Models: CNN-RNN Augmentation with Grad-CAM Analysis for Predicting Pneumonitis from Pre-Treatment CT Images
    Location: Hall C
    Presenter: P. Troy Teo, PhD – Northwestern University